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NAVIGATION OF THESIS 
 
 
This thesis is made up of five chapters. Chapter One provides an overview of the 
literature with specific focus on the role of the microvasculature in the development of 
cardiovascular disease, particularly in women. Background information on the theory and 
methodology behind automated measurement of both retinal vessel calibre and fractal 
dimension is also described in detail. In Chapter One, the purpose and aims of this thesis 
are outlined. 
 
Following Chapter One are three experimental studies, presented as three individual 
chapters (Chapters Two, Three, and Four).  Each of the three experimental studies (Study 
One, Two, and Three) are distinct bodies of work that address the experimental aims of 
this thesis.   
 
Chapter Five presents a discussion and conclusion section summarising the findings of 
the experimental studies in this thesis and provides information regarding the possible 
practical and/or clinical application of these findings. 
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ABSTRACT  
 
 
The primary aim of this thesis is to examine changes in retinal microvascular structure 
and asymmetric dimethylarginine (ADMA) concentration in women aged 65-74 yr with 
type 2 diabetes, following twelve weeks of controlled and supervised exercise training at 
individual gas-exchange threshold (Tge). In particular, this thesis examined the 
relationship between retinal vessel calibre/fractal analysis and measures of physiological 
functional capacity and endothelial function. Data from this thesis provide new 
knowledge on the effects of moderate intensity exercise on retinal microvascular 
morphology [retinal vessel calibre (RVC) and fractal dimension (Df)] and ADMA 
concentration in women with type 2 diabetes. The same subjects were recruited for all 
studies. 
Study One 
The purpose of Study One was to investigate the relationship among retinal vessel 
calibre, fractal dimensions and physiological functional capacity in females aged 65-74 
years with and without type 2 diabetes. Forty females (19 with type 2 diabetes and 21 
without type 2 diabetes) underwent graded treadmill exercise testing to voluntary fatigue. 
Retinal photographs were obtained at a clinical eye examination from which retinal 
vascular calibre and fractal dimensions were quantified using a computer-based program 
(IRIS and IVAN) and summarized as the central retinal artery equivalent (CRAE) or 
central retinal vein equivalent (CRVE) and Df. Subjects with type 2 diabetes had 
significantly lower peak oxygen uptake, peak heart rate, peak respiratory exchange ratio 
and time to exhaustion compared to age and gender-match subjects without type 2 
diabetes. There were no significant differences between subjects with or without type 2 
diabetes in CRAE (with diabetes 153.3±3.8 µm vs. without diabetes 154.7±2.7 µm, p = 
0.760), CRVE (with diabetes 220.2±4.4 µm vs. without diabetes 230.8±4.9 µm, p = 
0.121), or fractal dimension (with diabetes 1.45±0.004 vs. without diabetes 1.45±0.004, p 
= 0.595). In this sample of women aged 65-74 years, retinal vascular complexity 
(branching pattern) assessed as Df was found to be significantly correlated (r = 0.48, p = 
0.04) with time to exhaustion in individuals with type 2 diabetes.  These findings provide 
the first evidence of a significant association between measures of physiological 
 v 
functional capacity and retinal branching patterns in individuals with type 2 diabetes, 
which is considered a key parameter for the efficiency of microcirculation. 
Study Two 
While exercise training has been prescribed as a preventive and therapeutic intervention 
for cardiovascular disease in individuals with type 2 diabetes, the effects of exercise 
training on the retinal microvascular responses are not well described. Study Two 
investigated the effect of twelve weeks of supervised walking exercise on retinal vessel 
calibre and fractal dimension - markers of early microvascular complications - in women 
aged 65-74 years with type 2 diabetes. Fifteen women completed twelve weeks of 
supervised walking (120 minutes per week) at an intensity equivalent to their individual 
Tge. Retinal photographs were taken and microvascular responses to exercise (via 
maximal exercise tests) were assessed before and after a 6-week intervention-free control 
period, and again after 6 and 12-weeks of exercise training. Twelve weeks of exercise 
training at Tge resulted in significant increases in time to exhaustion (p < 0.001), peak 
oxygen uptake (VO2peak) (p = 0.016), VO2peak relative to body mass (p = 0.026), 
respiratory exchange ratio (p = 0.040), VO2 at Tge (p = 0.030), heart rate at Tge (p = 
0.033) as well as significant reductions in systolic (p = 0.014) and diastolic (p = 0.032) 
blood pressure. However, no significant changes in mean retinal vessel calibre or retinal 
fractal dimension were found after six or twelve weeks of exercise training. We could not 
document any significant changes in either RVC or Df after twelve weeks of moderate-
intensity, walking exercise in this sample of older women with type 2 diabetes. This 
contrasts with other studies showing that mild physical activity is associated with less 
adverse retinal microvascular signs. 
Study Three 
Basal plasma concentration of ADMA, an endogenous, competitive inhibitor of nitric 
oxide synthase, is elevated in patients with type 2 diabetes. ADMA may contribute to the 
endothelial dysfunction and associated vascular complications observed in individuals 
with type 2 diabetes. The purpose of Study Three was to investigate the effect of twelve 
weeks (120 minutes per week) of supervised walking exercise on plasma ADMA 
concentration in women aged 65-74 years with type 2 diabetes. Fourteen women (aged 69 
± 3 yrs) with uncomplicated type 2 diabetes, completed twelve weeks of supervised 
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walking at an intensity equivalent to their individual Tge. Blood was sampled for ADMA 
concentration before and after a 6-week intervention-free control period, and again after 
six and twelve weeks of exercise training. Plasma ADMA concentration was found to be 
significantly lower after twelve weeks of exercise training when compared with baseline 
(wk 0) measurements. These results were accompanied by significant increases in time to 
exhaustion, relative and absolute VO2peak, and VO2 at Tge. Regular, moderate-intensity 
exercise decreases circulating ADMA concentrations in older women with type 2 
diabetes. These results suggest that ADMA may play a role in the training-induced 
reduction in cardiovascular disease risk seen with exercise training in individuals with 
type 2 diabetes. 
Conclusion 
The findings presented in this thesis support the use of regular, moderate-intensity 
exercise as an effective intervention for the management of type 2 diabetes in older 
women aged 65-74 years. 
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 2 
An Overview of the Literature and Statement of Purpose 
  
1.1  Ageing, Exercise and Women’s Health 
During 1991-2001, the female population in Australia, aged 65-74 yr, increased by 
approximately 8% to 682,000 and is expected to increase to 1.28 million by 2021 
(Australian Institute of Health and Welfare 2006). The increasing number and life 
expectancy of older women in Australia poses a significant challenge and financial 
burden to our health-care system. Preventative and health promotion strategies must be 
developed for this group of Australians if chronic disease and disability are to be 
contained.  
 
Ageing is associated with a decline in physiological functional capacity (PFC) that 
impairs health, well-being and independent living (Singh 2002). However, the rate of 
decline in PFC is variable, with some individuals showing greater rate of decline than 
others. Regular exercise is one factor that may contribute to the variability in PFC 
observed with ageing (Tanaka and Seals 2003). There is strong evidence suggesting that 
regular exercise may slow the rate of decline in PFC (Pollock et al. 1987; Tanaka and 
Seals 2003). Asmussen et al. (Asmussen et al. 1975) studied a group of 65 yr old, 
chronically active physical-education teachers and found that, unlike the control group, 
there was no deterioration in their PFC over a 12-yr period. Similar findings have been 
reported by others (Fries 1996), strengthening the “exercise hypothesis” that regular 
exercise can slow the rate of decline in PFC. Indeed, Fries (Fries 1980) went as far as to 
say; “in the absence of cigarette smoking, participation in regular endurance exercise can 
postpone the onset of chronic disease symptoms and manifestations.” Evidence strongly 
suggests that the deleterious course of chronic diseases typically associated with ageing 
such as hypertension (Stewart 2002), type 2 diabetes (Orozco et al. 2008), osteoporosis 
(Kohrt et al. 1998), coronary artery disease (Mengelkoch et al. 1997) and the decline in 
cognitive function (Colcombe and Kramer 2003) can be positively modified by regular 
exercise. A recurring theme throughout the reviews (Colcombe and Kramer 2003; Kohrt 
et al. 1998; Mengelkoch et al. 1997; Orozco et al. 2008; Stewart 2002) was the 
importance to establish “the optimum exercise prescription” to achieve beneficial 
adaptations.  
 3 
The direct economic costs of physical inactivity on the Australian Health Care system 
are estimated to be approximately $1.5 billion per year (Econtech 2007). Approximately 
75% of older females are either physically inactive or exercise at a level insufficient to 
maintain or promote health benefits, a pattern that has remained essentially unchanged 
since 1989 (American College of Sports Medicine 2006). The most common medical 
problems managed by General Practitioners (GPs) for this age group involve circulatory 
(36%), musculoskeletal (23%) and respiratory (20%) complications (American College 
of Sports Medicine 2006). Evidence is accumulating that exercise is cardiorespiratory 
protective (Bassuk and Manson 2003; Powers et al. 2004), vascular protective 
(Hambrecht et al. 1998), musculoskeletal protective (Asikainen et al. 2004), and 
neuroprotective (Mattson et al. 2002). Regular exercise can compress morbidity (Fries 
1980, 2003; Winett et al. 2003) and significantly reduce the disability index (↓ 300%) in 
women (Bruce and Fries 2003). Fries (Fries 1996) reported that physically active middle-
aged and older women showed no significant increase in their disability index over an 8-
yr period while they maintained their running history. Physically inactive women over 
the same 8-yr period increased their level of disability three fold. For older women, 
moderate exercise such as walking represents a potent intervention with multi-focal 
systemic benefits. If exercise is to have health benefits, the appropriate dose of exercise 
must be known to achieve those benefits without incurring an increased risk of injury or 
attrition.  
We do not know the interaction effects of the key exercise prescription principles 
(intensity, duration, frequency, mode and total work) that will maximize health benefits 
desired by GPs for this group of Australians.  If exercise e.g., walking, is to be prescribed 
by GPs and other credentialed health professionals for their older female patients, health 
professionals need to know the effect size, the response time, and threshold point for 
select outcome measures if the desired health benefits are to be attained. While the 
benefits of regular exercise in this population are described (for review see Thomas et al. 
2006), key exercise prescription principles remain unclear. The proposed study will 
examine the effects of exercise, set at an intensity equivalent to individual gas exchange 
threshold, on select outcome measures in women aged 65-74 years old with and without 
type 2 diabetes. 
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1.2 Type 2 Diabetes Mellitus 
Type 2 diabetes is a metabolic disorder characterized by hyperglycaemia, insulin 
resistance, beta-cell dysfunction, and abnormal glucose, lipid and protein metabolism, 
resulting from defective insulin production, insulin action, or both (Thomas et al. 2006). 
Type 2 diabetes occurs mostly in persons over the age of 40 yr and accounts for about 
90% to 95% of all diagnosed cases of diabetes (Australian Institute of Health and Welfare 
2008) (Figure 1).  
 
Figure 1.  Age-specific prevalence of diagnosed type 2 diabetes, 2004-2005. (Australian 
Institute of Health and Welfare 2008)   
 
Traditionally, diagnosis of type 2 diabetes was based on either plasma glucose 
concentration or an oral glucose tolerance test. More recently, the American Diabetes 
Association has expanded the criteria for the diagnosis of diabetes to: A. glycosylated 
haemoglobin (HBA1c) value ≥ 6.5%; B. fasting plasma glucose concentration (FPG) ≥ 
126 mg/dL (7.0 mmol/L) (following no caloric intake for at least 8 h); C. 2-h plasma 
glucose ≥ 200 mg/dL (11.1 mmol/L) during a 75-g oral glucose tolerance test (OGTT); or 
D. a patient showing classic symptoms of hyperglycaemia or hyperglycaemic crisis and a 
random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) (American Diabetes Association 
2012b). Criteria for identifying individuals with increased risk of developing future 
diabetes, known as pre-diabetes (American Diabetes Association 2012a), have also been 
established. According to the American Diabetes Association, individuals with: A. FPG 
100mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (impaired fasting glucose); and/or 
B. 2-h plasma glucose between 140 mg/dL (7.8 mmol/L) and 199 mg/dL (11.0 mmol/L) 
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during a 75-g OGTT [impaired glucose tolerance (IGT)]; and/or C. HBA1c 5.7-6.4% 
should be considered to be at high risk for developing diabetes (American Diabetes 
Association 2012b). 
 
Due to the progressive nature, type 2 diabetes is frequently undiagnosed until overt 
complications appear. In Australia, population studies have estimated that there may be 
as many as one case of undiagnosed diabetes for every known case (Dunstan et al. 2002). 
Given that diabetic trials have proven lifestyle interventions to be effective in 
significantly decreasing the rate of onset of diabetes (Knowler et al. 2002; Tuomilehto et 
al. 2001), early identification of diabetes risk is essential. Due to the significant pre-
symptomatic phase often associated with type 2 diabetes, the American Diabetes 
Association (American Diabetes Association 2012b) has established criteria for testing 
for diabetes in asymptomatic adult individuals. The American Diabetes Association 
(American Diabetes Association 2012b) suggests that testing should be considered for all 
adults who are:  
1.  Overweight [body mass index (BMI) ≥ 25 kg/m2] and have one or more 
additional risk factors: 
• physical inactivity 
• first degree relative with diabetes 
• high-risk race/ethnicity 
• women who delivered a baby weighing > 9lb or who were diagnosed with 
Gestational Diabetes 
• hypertension (blood pressure ≥ 140/90 mmHg) 
• HDL cholesterol level < 35 mg/dL and/or a triglyceride level > 250 mg/dL 
• women with polycystic ovary syndrome 
• HbA1c ≥ 5.7%, IGT, or impaired fasting glucose (IFG) on previous testing 
• history of cardiovascular disease (CVD) 
2. In the absence of the above criteria, testing should begin at age 45 years 
3. If results are normal, testing should be repeated every 3 years 
     (American Diabetes Association 2012b) 
Long-term type 2 diabetes is associated with with macrovascular (coronary, peripheral 
vascular), microvascular (retinal, renal), and neuropathic (autonomic, peripheral) 
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complications. Type 2 diabetes is associated with older age, obesity, family history of 
diabetes, history of gestational diabetes, impaired glucose metabolism, physical 
inactivity, and race/ethnicity. Diabetes is recognized as one of Australia’s top nine 
National Health Priority Areas (NHPAs) (Australian Institute of Health and Welfare 
2010), with an estimated 5.2% of all deaths directly due to diabetes (Roglic et al. 2005).  
With approximately 90000 Australians diagnosed every year with type 2 diabetes 
(Dunstan et al. 2002), effective prevention strategies and treatment options has become a 
high health priority. The Australian Institute of Health and Welfare estimates the direct 
health-care expenditure on diabetes to be $907 million, nearly 2% of the allocated 
recurrent health expenditure (Australian Institute of Health and Welfare 2008).  Obesity 
and physical inactivity represent two major modifiable risks factors for type 2 diabetes 
in adults and represent key risk factor foci of prevention and treatment. Recent statistics 
suggest that 51% of Australians aged 15 years or older are overweight or obese and 70% 
did insufficient physical activity to promote or maintain health (Australian Institute of 
Health and Welfare 2008). Of all the complications associated with type 2 diabetes, 
cardiovascular disease is the leading cause of death in individuals with the disease 
(Australian Institute of Health and Welfare 2008). 
 
1.3 Type 2 Diabetes Mellitus and Atherosclerosis 
“A man is as old as his arteries” 
- Thomas Sydenham (1624-1689) 
 
Type 2 diabetes magnifies the risk of CVD morbidity and mortality in older individuals 
(Resnick et al. 2001). Numerous factors have been identified that increase the risk of 
developing CVD, including – but not limited to – heredity, physical inactivity, smoking, 
impaired fasting glucose, hypertension, dyslipidaemia, and age (Roger et al. 2012).  
Cardiovascular disease (central and peripheral vascular disease) is also a major 
complication associated with type 2 diabetes. Since CVD is the principal complication in 
type 2 diabetes and a major cause of death and disability in older individuals (Howard 
and Magee 2000), early detection and prevention of type 2 diabetes is important to the 
individual and to the health system. Estimates are that up to 75% of individuals with type 
2 diabetes will die of CVD (de Jager et al. 2006).  Peripheral vascular dysfunction is well 
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documented in sedentary older individuals and in individuals with type 2 diabetes 
(Bernard et al. 2005; Zeiher et al. 1991).  An integral part of that vascular dysfunction is 
endothelial function (Wang et al. 2006a). Individuals with clinically evident 
cardiovascular disease (or cardiovascular risk factors) demonstrate an impaired ability of 
the vascular endothelium to respond to appropriate stimuli.  In these individuals, evidence 
of endothelial dysfunction predicts adverse outcomes (Halcox et al. 2002; Perticone et al. 
2001). While patients with acute coronary syndrome demonstrated endothelial 
dysfunction, improved endothelial function was achieved by repeated bouts of exercise 
and associated with improved health outcomes (Schachinger et al. 2000).  Understanding 
the link between type 2 diabetes and CVD is an important step in establishing effective 
medical therapy. 
 
1.4 Diabetes and Endothelial Function 
 
The epidemiology and pathophysiology of changes in blood vasculature with diabetes 
remains uncertain.  What is known is that clinical conditions that accompany diabetes 
(e.g. hyperglycaemia, hyperlipidaemia, insulin resistance) cause arterial dysfunction and 
render arteries susceptible to atherosclerosis (for review see Beckman et al. 2002).  
Figure 2 outlines the cascade of consequences of diabetes mellitus on endothelial 
function, which ultimately leads to atherosclerosis.  
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Figure 2. Endothelial dysfunction in diabetes.  (Beckman et al. 2002). 
 
The endothelium is a thin layer of cells that line the interior surface of blood vessels and 
form an interface between circulating blood and vessel walls (for review see Davignon 
and Ganz 2004).  The endothelium provides a metabolically active interface between 
blood and vessel walls that allows for nutrient delivery, coagulation and thrombosis 
(Cines et al. 1998) and synthesizes bioactive substances [e.g. nitric oxide (NO), 
endothelin-1] that regulate vasculature function and structure.  Diabetes impairs nitric 
oxide-mediated vasodilation as well as increases the production of vasoconstrictors 
(endothelin-1) (Beckman et al. 2002), which leads to atherosclerotic changes in the 
vasculature. Together, changes associated with diabetes (i.e. hyperglycaemia, 
hyperlipidaemia, and insulin resistance) impair endothelial function, alter 
vasoconstriction, increase inflammation, and promote thrombosis, overall enhancing the 
initiation of atherogenesis and producing clinical signs/symptoms of atherosclerosis. 
 
 
 9 
1.5 Effects of Exercise on Endothelial Function 
The role of endothelial dysfunction in the development of atherosclerosis is well 
established, in particular, plaque formation, fibrinolysis and the regulation of arterial 
pressure (for review see Tousoulis et al. 2010).  The effects of regular exercise on 
improving endothelial function have been well documented (for review see Ghisi et al. 
2011).  Evidence suggests that exercise-induced activation of the NO pathway is an 
important mechanism in the vascular improvements associated with repeated bouts of 
exercise (for review see Ghisi et al. 2011).  Endothelial-dependent vasodilation has been 
shown to increase with regular exercise and is principally mediated by NO (Casillas et al. 
2007).  Repeated bouts of exercise stimulate the expression of molecular factors involved 
in NO production (Dimmeler and Zeiher 2003; Fukai et al. 2000).  Figure 3 shows the 
proposed adaptation of peripheral and coronary vasculature to exercise as proposed by 
Maiorana et al (Maiorana et al. 2003).  Figure 3 (Panel A), shows an untrained vessel in 
which baseline endothelial release of NO (shown in yellow), which diffuses to smooth 
muscle, activates guanylate cyclase (GC) leading to production of cyclic guanosine 
monophosphate (GMP).  Cyclic GMP leads to calcium channel opening and causes 
smooth muscle relaxation and vasodilation of the vessel.  Figure 3 (Panel B) shows a 
vessel after several weeks of exercise training. The repeat bouts of exercise are suggested 
to increase the shear stress along the vessel wall as a result of pusatile blood flow, which 
stimulates increased endothelial NO production and the consequent vasodilation 
(Maiorana et al. 2003).  Up-regulation of endothelial nitric oxide synthase (NOS) 
expression occurs as means of buffering increased shear stress. Figure 3 (Panel C) 
depicts structural adaptations (increased vessel calibre) that occur following long-term 
exercise training.  Chronic increases in vessel calibre are seen due to NO-mediated 
changes in smooth muscle cells and NO function returns towards baseline levels 
(Maiorana et al. 2003).  Exercise training has been established to positively modify flow-
dependent, endothelium-mediated vasodilation in patients with cardiovascular disease 
(Hambrecht et al. 1998; Hambrecht et al. 2003; Hornig et al. 1996) and in patients with 
type 2 diabetes mellitus (Maiorana et al. 2001).  While the effects of exercise on 
endothelial dysfunction in patients with diabetes have been examined, an exercise dose-
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response relationship remains unknown, as does the role of asymmetric dimethylarginine 
(ADMA), a NOS inhibitor.   
 
Figure 3.  Hypothesised response of arteries to increased flow and shear stress following 
varying duration of exercise training. (Maiorana et al. 2003). 
 
1.6 Type 2 Diabetes and CVD: Gender Differences 
 
Type 2 diabetes mellitus is associated with an increased risk of CVD, cerebrovascular 
disease, and peripheral vascular disease (Kanaya et al. 2002).  While type 2 diabetes 
increases the risk of CVD in both men and women, the increase in risk of CVD is more 
marked in women than in men (Avogaro et al. 2007; Juutilainen et al. 2004; Kanaya et al. 
2002).  Women with type 2 diabetes, compared to age-matched women without diabetes, 
have a 5-to-7 fold higher rate of CVD death (Steinberg et al. 2000), producing event rates 
similar to those seen in similarly aged men with type 2 diabetes.   While the impact of 
gender on risk of CVD in individuals with type 2 diabetes is well established (Avogaro et 
al. 2007; Juutilainen et al. 2004; Kanaya et al. 2002), the mechanisms behind these 
gender differences remain uncertain.  In 2000, Steinberg (Steinberg et al. 2000) and 
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colleagues examined gender differences in endothelial function as a possible explanation 
for the elimination of the usual female advantage for CVD mortality.  They found that 
women exhibit higher rates of NO production than men and the gender differences in NO 
production is abrogated in type 2 diabetes, lessening the cardioprotective action of NO.  
In a 20-year follow up study, Hu et al (Hu et al. 2001) found that type 2 diabetes was 
associated with significant increases in the risk of total mortality and CVD death among 
women, increasing risk of fatal CVD to nearly that of conferred by prior CVD.  If the 
gender differences in CVD risk to diabetics are to be better understood, further studies 
are required to examine the effects of diabetes on NO action, along with NO synthase 
inhibitors, including ADMA. 
 
1.7 Type 2 Diabetes Mellitus and Exercise 
 
Together with medication and diet intervention, exercise has been well established as an 
effective intervention in the management of type 2 diabetes (Marwick et al. 2009).  To 
date, several studies (for review see Thomas et al. 2006) have investigated the effect of 
repeated bouts of aerobic exercise on type 2 diabetes in various populations.  Significant 
decreases in glycaemia (Lee et al. 2005), increases in insulin sensitivity, insulin secretion 
and/or decreases in HbA1c concentration (Boule et al. 2001; Hulver et al. 2002; Mourier 
et al. 1997; Thomas et al. 2006; Willey and Singh 2003), reduction in BMI, total fat 
mass, sum of skin-fold measurements, waist and/or waist-to-hip ratio (Christ-Roberts et 
al. 2004; Hulver et al. 2002; Lee et al. 2005; Ross et al. 2004), improvements in 
cardiovascular risk profile (increase of high-density lipoprotein/low-density lipoprotein 
(HDL/LDL) ratio, normalization of blood lipid profile and a reduction of systolic and 
diastolic blood pressure) (Banz et al. 2003) have all been documented benefits of aerobic 
exercise in individuals with type 2 diabetes. 
 
Skeletal muscle consumes between 70% to 90% of glucose transported in blood 
(Lambers et al. 2008).  Single bouts of exercise have been reported to increase active 
muscles’ insulin sensitivity, while regular exercise has been shown to cause long-term 
improvements in glycaemic control, both providing type 2 diabetics with lowered insulin 
requirements (Lambers et al. 2008).  Improved insulin sensitivity results from the 
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translocation of glucose transporter protein (GLUT-4) from the endoplasmic reticulum to 
the cell surface, increased total quantity of GLUT-4, and an increase in glycogen 
synthase activity and subsequent glucose storage as glycogen (Sigal et al. 2006).  The 
improved insulin sensitivity and the attending physiological effects resulting from regular 
bouts of exercise are important in the management of type 2 diabetes. 
 
1.8 Asymmetric Dimethylarginine 
 
1.8.1 Nitric Oxide and Vascular Homeostasis 
 
Endothelium-derived NO is an endogenous vasodilator, important to flow-mediated 
vasodilation and a critical modulator of blood flow and blood pressure (Pohl et al. 1986; 
Rees et al. 1989).  Loss of NO activity has been shown to accelerate the development of 
vascular lesions, occurring early in the course of vascular disease (Celermajer et al. 
1994).  Evidence has shown that a reduction in endogenous NO may play an important 
role in increasing vascular resistance and the initiation and development of 
atherosclerosis and therefore may be predictive of vascular events (Cooke 2000).  
Endothelial dysfunction, via changes in the NO pathway are caused primarily by 
reductions in:  (i) NO half-life, (ii) NO sensitivity, (iii) NOS expression, and (iv) NOS 
activity (Cooke 2000).  There is accumulating evidence that endogenous inhibition of 
NOS activity may be responsible for much of the endothelial dysfunction seen in 
individuals with vascular disease and cardiovascular risk factors (Cooke 2000).  The most 
predominant endogenous inhibitor NOS activity is ADMA. 
 
1.8.2 Asymmetric Dimethylarginine, Nitric Oxide Synthase, and Endothelial 
 Dysfunction 
 
ADMA is an endogenous competitive inhibitor of NOS (Lin et al. 2002).  ADMA has 
been implicated in the progression of endothelial dysfunction, limiting the synthesis of 
vasoprotective NO and accelerating atherosclerosis (Cooke 2005).  Plasma levels of 
ADMA have been found to be increased in conditions associated with atherosclerosis and 
with cardiovascular risk factors, including age, hypertension, hypercholesterolemia, 
hypertriglyceridemia, hyperhomocysteinaemia, insulin resistance and diabetes (Abbasi et 
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al. 2001; Boger et al. 1998; Miyazaki et al. 1999; Stuhlinger et al. 2002).  Current 
evidence suggests that ADMA levels may be predictive of cardiovascular events and may 
be an independent risk factor for central and peripheral vascular disease (Cooke 2005).  
By blocking NO synthesis, ADMA promotes vasoconstriction, along with inflammatory, 
oxidative, proliferative and adhesive processes crucial in atherogenesis (Richter et al. 
2005).  Small changes in ADMA concentrations have been found to significantly alter 
vascular NO production, vascular tone, and systemic vascular resistance (Boger 2003).  
The pathophysiological roles of elevated ADMA levels, resulting from its inhibition of 
endothelial NO formation can be seen in Figure 4. 
 
Figure 4.   Pathophysiological consequences of elevated ADMA concentrations. (Boger 
2004). 
 
1.8.3 Asymmetric Dimethylarginine, Type 2 Diabetes Mellitus, and Vascular 
 Disease 
 
While CVD is a major cause of morbidity and mortality in individuals with type 2 
diabetes (Astrup 2011), the elevated incidence of CVD cannot be fully explained by the 
presence of conventional risk factors (Hayden and Reaven 2000).  Recent studies have 
presented compelling evidence for the association between elevated ADMA 
concentration and atherosclerosis (Abbasi et al. 2001; Cooke 2005). Conditions 
associated with atherosclerosis, including type 2 diabetes mellitus, are associated with 
increased plasma ADMA concentration (Abbasi et al. 2001; Cooke 2005).  In 2001, 
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Abbasi and colleagues (Abbasi et al. 2001) examined plasma ADMA concentrations in 
normal volunteers and in individuals with type 2 diabetes. Significantly higher ADMA 
concentrations were found in individuals with type 2 diabetes matched for age, gender 
distribution, body mass index, and total and low-density lipoprotein cholesterol 
concentrations (Abbasi et al. 2001) (Figure 5). The increased incidence of cardiovascular 
disease associated with diabetes cannot be explained by traditional risk factors, leading to 
suggestions that ADMA’s role in NO synthase inhibition is a possible factor in the 
accelerated atherogenesis associated with type 2 diabetes (Abbasi et al. 2001; Boger et al. 
1998; Fard et al. 2000; Hayden and Reaven 2000; Lin et al. 2002).   
 
 
Figure 5.   Comparison of plasma ADMA concentration (µM/L) in normal subjects and    
patients with type 2 diabetes. (Abbasi et al. 2001). 
 
1.8.4 Asymmetric Dimethylarginine and Exercise 
 
To date, no studies have investigated the effects of repeated bouts of exercise on ADMA 
concentration in individuals with type 2 diabetes mellitus.  However, in persons at risk of 
CVD, exercise has been shown to reduce ADMA concentration (Richter et al. 2005), with 
those persons showing significant down-regulation of circulating ADMA concentration 
after twelve weeks of aerobic exercise at moderate intensity.  These results suggest 
lifestyle modifications, such as regular exercise, may be a considered approach to reduce 
ADMA concentration.  The effects of repeated bouts of exercise upon ADMA 
concentration may in part explain previously unknown mechanisms for observed 
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improvements in endothelial function following exercise training (Boger et al. 1998).  
While the current literature on the effects of exercise on ADMA concentration is sparse, 
information on a possible dose-response relationship between decreases in plasma 
ADMA concentrations and exercise is non-existent. Another proposed marker of 
endothelial function is retinal microvascular morphology. 
 
1.9 Retinal Vascular Calibre as a Mirror of Microvascular Changes 
 
Retinal vasculature provides a direct and non-invasive view of the condition of 
microcirculation (Wong et al. 2001b). Retinal arterioles and venules share many 
anatomical and physiological characteristics with the cerebral, coronary, peripheral, and 
renal microcirculations (Klein et al. 2007). Studies have shown that changes in retinal 
vascular calibre (RVC) [i.e., retinal arteriolar narrowing, retinal venular widening and 
reduced ratio of arterioles/venules (AVR)] have been associated with CVD, including 
stroke (Wong et al. 2001a), coronary heart disease, hypertension and metabolic disorders 
(Wong et al. 2002c).  Studies have also shown that retinal vascular changes are associated 
with heart failure (Wong et al. 2005a) and cardiovascular mortality (Klein et al. 2004) in 
individuals with type 2 diabetes.  It has been suggested (Wong et al. 2002c) that the 
underlying basis for the association between retinal vessel calibre and vascular disease 
may be related to endothelial dysfunction. Particularly relevant to the proposed study is 
the well-documented relationship between RVC and CVD. The relationship between 
RVC and CVD has been reported to be stronger in women than in men (Duncan et al. 
2002; Tedeschi-Reiner et al. 2005; Wong et al. 2002c), thereby raising the significance of 
the proposed study.  The reasons for the stronger relationship between RVC and CVD in 
women are unclear. Studies have suggested that in women, endogenous oestrogen may 
play a cardioprotective role before menopause and with the onset of menopause, the 
reduction in oestrogen accelerates the rate of CVD post menopause (Hodis et al. 2001).  
The decline in plasma oestrogen concentration has been suggested as a significant 
contributory factor to the accelerated rate of CVD.  Studies have also suggested that the 
stronger relationship between RVC and CVD in women is that microvascular disease 
may have a greater role in the pathogenesis of CVD in women than in men (Buchthal et 
al. 2000; Hasdai et al. 1998; Reis et al. 1999).  While some clinicians have begun to 
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include retinal photography as a component of their clinical evaluation of women at risk 
of myocardial ischaemia and CVD (Shaw et al. 2004), other clinicians have stressed the 
need to confirm the categorical link between endothelial dysfunction and increased risk 
of CVD in postmenopausal women (Bressler 2003; Maguire 2003).  Understanding the 
contribution of microvascular processes to the risk of CVD may prove important in 
establishing preventative and therapeutic interventions (Wong et al. 2002c), including a 
prescribed dose of regular exercise.     
 
By using non-invasive measurement of retinal vessels (fundus photography and 
computerized analysis), the retinal vasculature may provide a useful surrogate marker of 
endothelial dysfunction and how selected doses of exercise might affect system-wide 
endothelial function.  Changes in retinal vasculature (eg. retinal arteriolar narrowing, 
retinal venular widening and reduced AVR) may be used as markers of early pre-clinical 
stages of cardiovascular diseases and metabolic disorders (Liew et al. 2008c) (Table 1).  
A better understanding of the associations between retinal vasculature and markers of 
CVD and the interaction between them may allow for use of retinal microvascular calibre 
as a biomarker for sub-clinical disease and a surrogate marker for cardiovascular 
response to therapy.  By examining stimuli that improve endothelial function, e.g. regular 
exercise, a better understanding of the mechanism(s) for the improvements in endothelial 
function with regular exercise may be proposed.   
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Table 1. Conditions associated with changes in central retinal artery equivalent (CRAE) 
and central retinal vein equivalent (CRVE). 
 
CRAE                                          _ 
Smaller CRAE is associated with: 
• Aging 
• Higher blood pressure 
(Current/Past) 
• Smaller optic disc 
• Obesity/BMI 
• Migraine 
• Hypertension 
• Stroke 
 
Larger CRAE is associated with: 
• Progression of retinopathy 
CRVE                                        _ 
Larger CRVE is associated with: 
• Obesity 
• BMI 
• Inflammatory marker 
• Diabetes 
• Metabolic Syndrome 
• Low HDL cholesterol 
• Diabetes 
• Obesity 
• Progression of retinopathy 
• CHD 
• Cardiovascular mortality 
 
1.9.1 Assessment of Retinal Vessel Diameters – IVAN Software 
 
IVAN is a system developed at the University of Wisconsin as a semi-automated means 
of measuring retinal vessel widths (CRAE/CRVE) from digital retinal images (Figure 6). 
 
 
Figure 6.  Sample of retinal photo taken from a patient for grading of retinal vessel  
      calibre. 
 
During analysis, IVAN software places an overlying grid centred on the optic disc, and 
proceeds to identify blood vessel types and measure widths of the identified blood 
vessels. Specifically, IVAN software measures internal vessel calibre or erythrocyte 
column width.  Venules are denoted by the colour blue and arterioles are denoted by the 
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colour red.  As seen in Figure 7, all retinal vessels passing through an area between 0.5 
and 1.0 standard disc diameters from the optic disk (Zone B) are identified and measured.  
Trained graders are able to override any initial automated decisions or measurements, 
including grid placement, changing vessel type, deleting vessels or adding missed 
vessels. 
 
 
Figure 7.  Retinal vessel diameters passing through an area between circles with a 0.5 
and 1.0 standard disc diameters from the optic disc margin (Zone B). 
 
Measurement results are calculated, using the six largest venules and six largest 
arterioles, as CRAE, CRVE, and AVR, providing estimated central retinal artery and vein 
diameter based on branch measurements.  AVR provides a ratio between CRAE and 
CRVE measurements.  Figure 8 depicts two retinal photographs from two different 
individuals. One photograph (A) shows a retinal photograph with a low AVR [arterioles 
(white arrows) are smaller than venules (black arrows)] and a second photograph (B) 
shows a retinal photograph with a high AVR (arterioles are wider than venules). 
 
1DD 
0.5DD 
OD 
Zone A 
Zone B 
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Figure 8.  The AVR of two retinal photographs. (A) Low AVR and (B) High AVR.  
(Wong et al. 2004b). 
 
1.10 Fractal Analysis of the Retinal Microvasculature 
 
1.10.1 Fractal Geometry – Fractals in Biology 
 
“I conceived and developed a new geometry of nature and implemented its use 
in a number of diverse fields. It describes many of the irregular and 
fragmented patterns around us, and leads to full-fledged theories, by 
identifying a family of shapes I call fractals.”  
— Benoit Mandelbrot, 1983 
 
A fractal, first coined by Beniot Mandelbrot, is "a rough or fragmented geometric shape 
that can be split into parts, each of which is (at least approximately) a reduced-size copy 
of the whole", a property known as self-similarity (Mandelbrot 1983).   
 
Fractals are often considered to be infinitely complex, with greater complexity revealed 
under magnification (Figure 9).  As most physical systems are not easily described 
through Euclidian geometry, fractals have been used to describe, measure and predict 
complex natural structures (e.g. branching patterns of trees, coastlines, snowflakes, and 
lightning bolts).      
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Figure 9.  Example fractal images displaying self-similarity and increasing complexity 
under magnification. (Source: www.fractal.org). 
 
The theory that fractal geometry may serve as a design principle underlying living 
organisms has been elegantly presented (Weibel 1991). The application of fractal analysis 
to biology and medicine has recently gained much interest. When applied to branching 
structures in tissues and organs, fractal analysis has allowed for discrimination between 
normal and abnormal or pathological structures (Masters 2004). Fractal analysis has been 
successfully used in treatment and tracking the progress of Parkinson’s Disease (Sekine 
et al. 2004), Alzheimer’s Disease (Nagao et al. 2001), and Multiple Sclerosis (Esteban et 
al. 2009). Fractal analysis has also been applied in coding region detection in DNA and 
measurement of space-filling properties of tumours and blood vessels (Cross 1997).   
 
A long-standing problem in vascular pathophysiology is the characterization of blood 
vessel patterns.  Atherosclerosis, cancers, infections, stroke, hypertension, diabetes, 
obesity, and Alzheimer’s Disease are associated with changes in vascular morphology 
and organization, along with normal aging (Lorthois and Cassot 2010).  By characterizing 
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vascular branching structures into fractal dimensions, changes in vascular complexity 
may become a useful indicator of early, pre-clinical vascular change.  Research has 
shown that the retinal vasculature exhibits “self-similarity” and its vascular tree can be 
considered a fractal structure (Macgillivray et al. 2007; Mainster 1990; Masters 2004; 
Stosic and Stosic 2006), and can be quantified through analysis of digital retinal images. 
 
1.10.2 Retinal Vascular Fractals 
 
The application of fractal analysis to human retinal circulation was first introduced in 
1989 (Family et al. 1989; Masters and Platt 1989).  Using early techniques of calculating 
Df, Masters and colleagues were able to estimate a retinal Df of 1.7, which is consistent 
with a diffusion-limited growth process, the random growth process by which fractals are 
formed (Masters 2004).  
  
1.10.3 Assessment of Retinal Fractal Dimensions – International Retinal Imaging 
 Software 
 
International Retinal Imaging Software, or IRIS, is a semi-automated grading program 
which aims to measure the Df of retinal vasculature.  By calculating the Df for digital 
retinal photos, the branching patterns of the retinal vascular tree can be summarized as an 
estimate of the amount of “space” a fractal pattern occupies (Figure 10).  The Df 
provides a more global measure of retinal microvascular structure than CRAE, CRVE or 
AVR (as measured by IVAN software) by taking into account both retinal vessel calibre 
and vascular branching patterns (Liew et al. 2008b).  
 
 
 
 
 
 
 
 
 
Figure 10. IRIS automated calculation of Df. 
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1.10.4 Use of Retinal Vascular Fractals 
 
While research into retinal vascular fractal analysis is still developing, a number of 
significant relationships have been found.  Data from Liew et al. (Liew et al. 2008b) 
(Figure 11) shows that Df exhibits a significant inverse relationship with systolic blood 
pressure (SBP), suggesting that Df may be a measure of early changes in microvascular 
structure from elevated systolic blood pressure.  
 
 
 
Figure 11.   Fractal dimension and systolic blood pressure in 300 participants of Blue 
Mountain Eye Study. (Liew et al. 2008b). 
 
Liew et al. (Liew et al. 2008b) found the relationship between Df and SBP to be even 
stronger than that of RVC and SBP, suggesting that fractal dimension may be a more 
sensitive marker of microvascular structural change than RVC.  Variations in retinal 
vascular fractal dimension were also found to be inversely and significantly correlated 
with age (Liew et al. 2008b).  More recently, deviations from optimal microvascular 
architecture (high or low Df) have been shown to be associated with chronic kidney 
disease (CKD) (Sng et al. 2010).  Independent of age, gender, ethnicity, diabetes, blood 
pressure, and other vascular risk factors, high (more complex) and low (less complex) 
retinal Df was associated with increased risk of CKD.  Figure 12 shows examples of 
retinal vessel fractal patterns exhibiting (A) high vascular complexity, (B) intermediate 
vascular complexity, and (C) low vascular complexity. 
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(A) shows a Df of 1.4958 
  
(B) shows a Df of 1.4541 
  
(C) shows a Df of 1.4073 
Figure 12.  (A) An eye with a high fractal dimension (Df = 1.4958). (B) An eye with an 
intermediate fractal dimension (Df = 1.4541). (C) An eye with a low fractal 
dimension (Df = 1.4073). (Sng et al. 2010). 
 
In a study examining the relationships between retinal vascular Df and long-term 
diabetes-related micro and macro vascular complications in individuals with type 1 
diabetes, retinal Df was shown to be associated with microvascular complications of 
proliferative retinopathy and neuropathy, but not macrovascular disease (Grauslund et al. 
2010).  Despite positive findings, further studies examining systemic correlates, disease-
predictive value, and responses to therapeutic interventions of retinal fractal analysis are 
clearly needed.   
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1.11 Exercise and Retinal Microvasculature 
 
Individuals with type 2 diabetes experience impaired microvascular function 
(Middlebrooke et al. 2006).  Jaap et al. (Jaap et al. 1995) found that individuals with type 
2 diabetes have increased risk of microvascular complications, even in the absence of 
traditional microvascular complications of the disease.  It has been suggested that 
microvascular dysfunction may be a key modulator in endothelium abnormalities seen in 
diabetic patients (Tooke and Hannemann 2000).  While evidence suggests that regular 
exercise can improve macrovascular endothelial function in diabetic populations (for 
review see Sonne et al. 2007), evidence demonstrating improvements in microvascular 
endothelial function following regular exercise is limited (Middlebrooke et al. 2006).  
Hamburg et al. (Hamburg et al. 2007) reported that physical inactivity was associated 
with development of impaired microvascular function in healthy volunteers, suggesting 
that microvasculature is highly sensitive to metabolic changes associated with physical 
inactivity.  To date, a few studies have examined the association between retinal vessel 
calibre and levels of physical activity/inactivity (Anuradha et al. 2011a; Anuradha et al. 
2011b; Anuradha et al. 2011c; Tikellis et al. 2010). In the population-based 
Atherosclerosis Risk in Communities (ARIC) Study, lower levels of self-reported 
physical activity were shown to be significantly associated with wider venular calibre 
(Tikellis et al. 2010). In men, but not women, sedentary behaviour (prolonged television 
viewing time) has been shown to be associated with wider venular calibre (Anuradha et 
al. 2011a). No significant relationship was found between levels of physical activity and 
retinal vascular calibre in either gender. In the Multi-Ethnic Study of Atherosclerosis, 
lower levels of physical activity and higher levels of television viewing time were 
associated with wider retinal venular calibre (Anuradha et al. 2011b). In a multiethnic 
Asian population, lower physical activity and higher television time (in females) was 
associated with wider retinal venular calibre (Anuradha et al. 2011c). In these studies 
(Anuradha et al. 2011a; Anuradha et al. 2011b; Anuradha et al. 2011c; Tikellis et al. 
2010), physical activity was assessed via self- report, which is often subject to recall bias 
and misclassification. In order to effectively assess the relationship between retinal 
 25 
microvascular structure and physical activity, a more valid and reliable means of 
measuring varying levels of physical activity must be employed. 
 
1.12 Modifiable Lifestyle and Environmental Risk Factors Affecting the Retinal 
Microcirculation 
 
The retinal microcirculation may reflect healthy and pathophysiological processes 
affecting systemic circulation (Wong et al. 2005b). The vascular architecture within the 
retina, as well as elsewhere in the body, is thought to follow the principles of optimality, 
which allows the blood distribution to peripheral tissue within the quickest time with the 
least amount of energy (Murray 1926; Zamir 1976). Therefore, deviations from optimal 
structure of the retinal vasculature (e.g. arteriolar narrowing, venular widening) may 
represent deviation of the circulation from its optimal state, indicating pathophysiological 
processes. 
 
During the last few decades, the retinal vasculature has received increasing attention. 
With the advancement of retinal imaging, the retinal vasculature may allow non-invasive 
visualization to examine and monitor human circulation systems in vivo (Figure 13). For 
example, computer-based analysis techniques from digital retinal images has allowed for 
accurate and reproducible measurement of several parameters of the retinal vasculature 
(e.g. calibre, fractal dimension [complexity of vessel network], and branching angle) 
(Benitez-Aguirre et al. 2011; Cheung et al. 2009; Liew et al. 2008c; Wong et al. 2001b; 
Wong et al. 2003). A number of large-scale epidemiological studies have demonstrated 
that subtle changes in these parameters carry important information regarding the future 
risk of systemic vascular diseases (Ikram et al. 2004; Klein et al. 2004; Klein et al. 2000; 
Liew et al. 2008c; Liew et al. 2011; Sun et al. 2008; Wong et al. 2001b; Wong et al. 
2002a; Wong et al. 2006). 
 
Importantly, changes in the retinal vasculature have also been shown to have strong 
associations with systemic and environmental cardiovascular risk factors in a range of 
populations (for review see Sun et al. 2009), even before the clinical manifestation of 
cardiovascular disease. These subtle retinal vascular changes have been suggested to 
mirror pre-clinical changes in both the cerebral (Kwa 2006) and coronary (Tedeschi-
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Reiner et al. 2005) microcirculations. Although the mechanisms behind the association 
between retinal vascular changes and systemic cardiovascular risk factors have yet to be 
resolved, this relationship suggests that abnormalities in the retinal vasculature 
incorporate a cumulative effect of systemic damage. 
 
Recently, many of the largest determinants of sub-optimal retinal microvasculature have 
been found to be modifiable (Liew et al. 2008c), such as diet and medications. More 
importantly, information regarding these modifiable exposures, together with measures of 
the retinal vasculature, may eventually provide clinically useful prognostic information 
regarding systemic disease risk prediction beyond current traditional risk factor 
assessment. In this review, we summarize recent research examining the modifiable 
lifestyle and environmental determinants affecting the retinal microvasculature and 
potential clinical implications of these findings.  
 
 
(A) 
 
(B) 
 
Figure 13. (A) Examples of retinal vascular images with different morphologies, 
showing, from left to right, decreasing arteriolar calibre and vessel density.  
(B) Measurement of retinal arteriolar and venular calibre.  
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1.13 The Influence of Modifiable Lifestyle and Environmental Risk Factors on the 
Retinal Microvasculature 
 
1.13.1 Diet 
 
Dietary fibre intake, regular fish consumption, and low glycaemic index (GI) diets, such 
as those low in sugars and simple carbohydrates, are all associated with reduced risk of 
vascular disease (Brand-Miller et al. 2009; King 2005; Kris-Etherton et al. 2002). 
Emerging data suggest that the relationship between diet and macrovascular disease may 
partly be mediated by associated changes in the microcirculation (Kan et al. 2007; 
Kaushik et al. 2008; Kaushik et al. 2009). Work by Kan et al. (Kan et al. 2007) has 
shown that diet may have effects on RVC in the general population. For example, data 
from the ARIC study showed that higher intake of dietary fibre was independently 
associated with wider retinal arteriolar calibre and narrower venular calibre, indicating a 
lower risk of cardiovascular diseases (Kan et al. 2007). Similarly, findings from the Blue 
Mountain Eye Study (BMES) also demonstrated beneficial effects of increasing 
frequency of fish consumption on retinal microvasculature independent of other 
cardiovascular risk factors (Kaushik et al. 2008).  
 
However, high-GI diets have been linked to deleterious anatomic changes in the retinal 
microvasculature (Kaushik et al. 2008; Kaushik et al. 2009). Kaushik et al. (Kaushik et 
al. 2009) found that high GI diets were associated with wider retinal venules and greater 
stroke mortality in persons 50 years and older. These findings suggest that post-prandial 
glucose may have deleterious effects on the cerebral microcirculation and may play a 
significant role in the relationship between diet and stroke mortality. More recent data 
from 823 schoolchildren aged 12.8 +/- 0.8 yr demonstrated that there was no association 
between a high-GI diet and retinal arteriolar or venular calibre (Lim et al. 2009). 
Evidence from the above study suggests a possible dose-dependent, cumulative effect of 
diet on the microvasculature over time.  
 
The physiological influence of diet on the retinal microcirculation is complex. Kan et al. 
(Kan et al. 2007) found that the effect of fibre intake on retinal microvascular calibre 
might be confounded by concurrent hypertension and dislypidaemia. This suggests that 
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the beneficial retinal microvascular changes seen with increased fibre intake may not be 
directly effected by fibre intake itself, but by associated decreases in adverse systemic 
conditions like hypertension and dislypidaemia.  For example, fish consumption is 
associated with increases in HDL (Bays et al. 2008). Increased concentration of HDL has 
a well-establish vasoprotective and anti-atherogenic effect (Miller 1987) and may alone 
explain the beneficial retinal microvascular changes associated with higher fish 
consumption. Findings demonstrating that the microvascular effects of diet were not 
evident in children free of systemic disease (Lim et al. 2009) supports this theory. 
Regular fish consumption, fibre intake, and low GI diets are all known to reduce systemic 
inflammation (Qi et al. 2006; Wall et al. 2010). Retinal microvascular changes are known 
to be affected by inflammatory factors (Klein et al. 2006b), and may be another 
biological mechanism through which diet mediates microvascular calibre. While the 
mechanisms underlying the above associations may not be completely understood, these 
data supports the vascular-protective effects of increased dietary fish, fibre, and low GI 
food consumption.  
 
1.13.2 Physical Activity and Exercise 
 
Sedentary behaviour, low levels of physical activity, and low cardiorespiratory fitness are 
all well-established risk factors for atherosclerosis and CVD (Laukkanen et al. 2002). 
Recent research has also shown the adverse effects of physical inactivity and low fitness 
extends to changes in microvascular structure (Anuradha et al. 2011a; Anuradha et al. 
2011b; Anuradha et al. 2011c; Gopinath et al. 2011b; Hanssen et al. 2011; Tikellis et al. 
2010). Sedentary behaviour, indicated by time spent watching television (TV), and lower 
levels of physical activity, assessed via self-report, were found to be associated with RVC 
(Anuradha et al. 2011a; Anuradha et al. 2011b; Anuradha et al. 2011c; Tikellis et al. 
2010), suggesting a deleterious consequence of decreased levels of physical activity and 
increased sedentary behaviour upon the microvasculature. In addition, the impact of 
physical activity on the retinal microvasculature was also observed in a cohort of 6-year 
children. In the study by Gopinath et al., children who spent more time in outdoor 
sporting activities had wider mean RVC than those who spent more time watching TV 
(Gopinath et al. 2011b). More importantly, retinal arteriolar narrowing associated with 
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each hour of daily TV viewing time in children was similar in magnitude to that 
associated with a 10mm Hg increase in systolic blood pressure (Gopinath et al. 2011b).  
 
Recently, evidence has been provided showing a relationship between higher levels of 
cardiovascular fitness and retinal microvascular structure (Hanssen et al. 2011). Higher 
cardiovascular fitness, as assessed by individual anaerobic threshold, was found to be 
associated with higher retinal arteriolar dilation and higher retinal AVR (Hanssen et al. 
2011). In addition, ten weeks of exercise training was also shown to induce arteriolar 
dilatation in obese individuals and increased AVR in both obese and lean individuals 
(Hanssen et al. 2011). Conflicting results were found in a study of older women with type 
2 diabetes in which no training-induced improvements in retinal vessel calibre were 
found after 12-weeks of moderate-intensity exercise (Serre, unpublished observation, 
2011). In this cohort however, increased retinal microvascular density, shown by 
increased Df was associated with increased time to exhaustion during incremental 
exercise testing (Serre, unpublished observation, 2011).  
 
Observed associations between physical activity and changes in the retinal 
microvasculature may provide in vivo evidence regarding the effect of repeated bouts of 
regular exercise on the systemic circulation. While the exact pathophysiological 
mechanisms behind these relationships is not known, recent research suggests that 
moderators of vascular tone, specifically NO and ADMA, may play a significant role. 
ADMA, a NOS inhibitor, has been shown to directly affect retinal arteriole and venule 
diameters (Hemminki et al. 2007). More recently, Hanssen et al. (Hanssen et al. 2011) 
found that exercise training-induced increases in arteriolar calibre were accompanied by 
significant decreases in ADMA, suggesting the NO/ADMA pathway may play a key role 
in the beneficial changes in microvascular structure associated with regular exercise.  
 
 
 
 
 
 
 30 
1.13.3 Obesity 
 
The effect of obesity on the retinal microcirculation has been established (Cheung et al. 
2007). Arteriolar calibre narrowing, venular calibre widening and lower AVR have been 
found to be associated with obesity in children and adult populations (Ikram et al. 2004; 
Klein et al. 2003; Klein et al. 2006b; Wang et al. 2006b; Wong et al. 2004a; Wong et al. 
2006), suggesting that obesity may cause deleterious microvascular changes before 
clinical signs and symptoms of vascular disease are present. In children, a greater BMI 
was associated with wider retinal venular calibre and narrower arterioles, weight and 
body surface area were associated with wider retinal venules only, and larger waist 
circumference was associated with narrower retinal arterioles (Taylor et al. 2007).  
 
In the Singapore Cohort Study of the Risk Factors for Myopia (SCORM) (Cheung et al. 
2007), greater BMI and weight were associated with wider RVC. Consistent with this 
evidence, other recent studies have also demonstrated that BMI and triceps skinfold 
(Gopinath et al. 2011a; Li et al. 2011) were associated with wider RVC and narrower 
RVC in healthy, pre-adolescent children. Such evidence provides support for the theory 
that obesity may have an early adverse effect on microvascular structure.  
 
While the mechanisms underlying the association between obesity and retinal vessel 
diameter are unclear, several possible explanations exist. Systemic inflammation is 
thought to contribute to the vascular complications associated with obesity (Berg and 
Scherer 2005). Systemic inflammation is also associated with changes in retinal venular 
calibre (Klein et al. 2006b), and therefore may be the mechanism which links obesity and 
changes in retinal microvascular structure. Obesity is also related to increased total blood 
volume (Oren et al. 1996), and retinal venular dilatation may be a regulatory response to 
maintain blood flow. These relationships between obesity and retinal microvascular 
changes may help explain the association between childhood obesity and complications 
such as hypertension, diabetes, and cardiovascular morbidity and mortality that occur 
later in life (Daniels 2009).     
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1.13.4 Cigarette Smoking 
 
The Rotterdam study (Ikram et al. 2004), Beaver Dam Eye study (BDES) (Klein et al. 
2006b), Multi-Ethnic Study of Atherosclerosis (MESA) (Wong et al. 2006), Wisconsin 
Epidemiologic Study of Diabetic Retinopathy (Klein et al. 2006b), and BMES (Kifley et 
al. 2007b) have all demonstrated a consistent association between wider retinal venular 
calibre and cigarette smoking, suggesting that adverse macrovascular outcomes 
associated with smoking may be partly mediated by deleterious changes in microvascular 
structure. More recently, the ARIC study has demonstrated a temporal association 
between past smoking and wider retinal venules, independent of current smoking status 
(Liew et al. 2008c), indicating that smoking may provoke long-term structural changes in 
microcirculation.  
 
In a study examining the relative importance of current and past systemic determinants of 
RVC, it was found that current smoking surpassed mean arterial blood pressure, higher 
white blood cell count, BMI, and LDL cholesterol levels as the strongest determinant of 
wider RVC (Liew et al. 2008c). The use of RVC as a marker of damage from prolonged 
smoking has been strengthened by recent observations reporting retinal venular widening 
in patients with a history of smoking (Jeganathan 2005; Rosenberg et al. 2005).  
 
Endothelial dysfunction and chronic inflammation have been shown to be associated with 
both RVC (Klein et al. 2006b; Wong et al. 2006) and smoking (Ambrose and Barua 
2004; Landmesser et al. 2004; Michaud et al. 2006), and may partially explain the 
observed associations between RVC and smoking. Further longitudinal studies are 
required if the cumulative consequences of lifetime exposure to smoking, as well as a 
timeline for improvement in RVC changes after cessation of smoking, are to be 
determined. More importantly, additional research into the pathophysiology underlying 
the association between RVC and smoking is clearly needed.  
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1.13.5 Medications 
 
The BDES (Wong et al. 2005b) and BMES (Leung et al. 2004; Liew et al. 2006) have 
examined the impact of specific medication use on retinal microvascular structure. These 
studies found associations between topical beta-blockers and retinal arteriolar and venular 
narrowing (Leung et al. 2004), and hormone replacement therapy and lower AVR (Liew 
et al. 2006). In the study by Thom et al. (Thom et al. 2009), it was shown that 
hypertensive patients receiving the calcium channel blocker, amlodipine besylate 
(Norvasc) had narrower arterioles than those receiving the beta-blocker atenolol. While 
these data suggest that anti-hypertensive treatment may prove useful in decreasing retinal 
arteriole narrowing due to hypertension, the effects of lowered BP were not accounted 
for. Generalized arteriole narrowing has been shown to be associated with past elevated 
blood pressure levels (Leung et al. 2003) and any relationship between anti-hypertensive 
medication and retinal microvascular structure may be due to associated decreases in 
blood pressure. 
 
In order to examine the effects of angiotensin-convering enzyme inhibitor (ACEI) and 
angiotensin-receptor blocker (ARB) therapy on retinal vessel diameter, Klein et al. (Klein 
et al. 2010) examined a cohort of normo-tensive individuals with type 1 diabetes 
receiving anti-hypertensive treatment. No significant effect of ACEIs or ARBs on retinal 
vessel calibre was found in this population. The lack of effect of anti-hypertensive 
treatment on retinal vessel calibre suggests that the beneficial effects of anti-hypertensive 
treatment on the retinal microcirculation may be limited to those individuals whose 
retinal arterioles would likely be narrowed at baseline, and any relationship may be 
mediated by associated reductions in blood pressure. Further studies, including healthy 
control subjects, are required to determine if anti-hypertensive medications have an effect 
on retinal microcirculation when controlling for improvements in systemic diseases. If 
certain medications are found to have direct beneficial effects on retinal microvascular 
structure, targeted therapeutic interventions may be used to manage pre-clinical signs of 
systemic disease. 
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1.13.6 Environment 
 
Epidemiological studies have demonstrated significant increases in cardiovascular 
morbidity and mortality with increased long- and short-tem exposure to air pollution 
(Brook et al. 2010). Impaired microvascular function has been suggested to play a role in 
the above associations. Recently, data from the population-based MESA has shown that 
retinal arteriolar calibre was narrower and RVC was wider among persons living in areas 
with increased long- and short-term exposure to fine particulate matter (PM2.5) (Adar et 
al. 2010). A 3 ųg/m3 increase in PM2.5 concentration was associated with arteriole 
narrowing equivalent to those seen with an age increase of seven years, a more traditional 
cardiovascular risk factor. The above association suggest that important vascular changes 
occur with small increases in long- and short-term exposure to air pollution. 
 
A wider venular diameter with chronic air pollution exposure is consistent with similar 
findings from studies examining the effects of smoking on retinal microvascular structure 
(Ikram et al. 2004; Jeganathan 2005; Kifley et al. 2007a; Klein et al. 2006a; Klein et al. 
2006b; Liew et al. 2008a; Rosenberg et al. 2005; Wong et al. 2006), and may be mediated 
in part by inflammation-related mechanisms. Long-term exposure to air pollution is 
known to promote inflammation and endothelial dysfunction (Briet et al. 2007; 
Simkhovich et al. 2008), and may lead to disruption of the microvascular autoregulatory 
function and venular widening within the retina. Practically, the above findings are 
important in that sub-clinical microvascular changes (arteriolar narrowing and venular 
widening) were reported in individuals exposed to PM2.5 levels, well below established 
regulatory thresholds (Adar et al. 2010). These data may provide information necessary 
to establish safer and more accurate regulatory air quality standards.    
 
1.14 Conclusions  
 
Recent work on selected modifiable risk factors and the retinal microcirculation has 
provided evidence relating modifiable lifestyle and environmental risk factors to adverse 
cardiovascular outcomes. Exposure to modifiable risk factors may affect systemic 
physiology, which is reflected in changes in the retinal microvascular structure. The 
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retina is an easily accessible site in which the human microcirculation can be visualized 
non-invasively and quantified. The potential use of retinal imaging as a biomarker of 
reversible pathophysiological processes within the systemic circulation is promising.  
 
Nevertheless, evidence showing that quantitative assessment of retinal microvasculature 
can provide prognostic information beyond the current traditional risk factors is limited. 
Currently, there have been no established reference levels for age, gender, or disease 
status, which therefore still limits the utility of retinal imaging as a tool to monitor 
cardiovascular and metabolic risk in asymptomatic patients or those who have other 
traditional, positive risk factors.  
 
More longitudinal studies are needed to determine if changes in retinal microvascular 
structure can be positively modified with various therapeutic interventions (e.g. diet, 
exercise). Retinal imaging and interpretation may provide clinicians with a diagnostic 
tool to assess the effects of specific interventions on disease progression. Research into 
the possible prognostic value of retinal imaging, and subsequent interpretation, in 
subjects without clinically evident systemic diseases, e.g. healthy children, may provide 
evidence of clinically significant associations between retinal vascular structure and 
disease risk factors. Long-term systemic disease risk stratification in childhood may 
provide clinicians with information necessary to target microvascular risk factors in 
therapeutic interventions, and before overt signs of systemic diseases become evident. 
Advancing our understanding of the pathophysiology behind changes in retinal 
microvascular structure in diseased states may aid in the development of novel prediction 
and intervention strategies for a range of systemic conditions.  Although retinal imaging 
shows promise as a powerful clinical tool, further epidemiologic research is needed if 
retinal imaging is to become widely used in disease-risk identification and management.  
 
 
 
 
 
 
 35 
Table 2. Summary of studies examining the modifiable lifestyle and environmental determinants affecting the retinal 
microvasculature. (Serre and Sasongko 2011). 
Risk Factors Authors Year of Publication Population Measured Exposure Observed Outcome 
Diet Kan et al. 2007 10,659 US adults (ARIC) Increased dietary fibre Wider retinal arteriolar and 
narrower venular calibre 
Diet Kaushik et al. 2008 3,654 adults aged 49+ years (BMES) Increased Fish consumption Wider retinal arteriolar and 
narrower venular calibre 
Diet Kaushik et al. 2009 3,654 adults aged 49+ years (BMES) High Glycemic Index Wider retinal venular calibre 
Diet Lim et al. 2009 823 Singapore School Children 12.8 +/- 0.8 yrs High Glycemic Index No significant association 
Physical Activity Gopinath et al. 2011b 2238 six-year-old Sydney students Increased sporting activities  Wider retinal arteriolar 
calibre 
    Increased TV viewing time Narrower retinal arteriolar 
calibre 
Physical Activity Anuradha et al. 2011a 2,024 Australian adults (AusDiab) Low self-reported physical activity No significant association 
    
Increased self-reported TV viewing 
time Wider retinal venular calibre 
Physical Activity Anuradha et al. 2011b 5,893 US adults from 4 racial/ethnic groups (MESA) Low self-reported physical activity  Wider retinal venular calibre 
    
Increased self-reported TV viewing 
time Wider retinal venular calibre 
Physical Activity Tikellis et al. 2010 15,792 US adults 45-64 years (ARIC) Higher self-reported physical 
activity Wider retinal venular calibre 
Cardiovascular Fitness Hassen et al. 2011 46 adult recreational runners  Higher cardiovascular fitness (AT) Wider retinal arteriolar 
calibre and higher AVR 
    10-week exercise program Retinal arteriolar dilatation in 
obese individuals 
Cardiovascular Fitness Serre et al. Unpublished observations 15 women 65-74 years with type 2 diabetes 12-week exercise program No significant changes 
Cardiovascular Fitness Serre et al. Unpublished observations 15 women 65-74 years with type 2 diabetes Increased time to exhaustion during graded exercise testing Increased fractal dimension  
Obesity Taylor et al. 2007 1,740 Sydney school children (SCES) Increased BMI & weight Wider retinal venular calibre 
    
Increase BMI & waist 
circumference 
Narrower retinal arteriolar 
calibre 
Obesity Cheung et al. 2007 768 Singapore school children (SCORM) Increased BMI & weight  Wider retinal venular calibre 
Obesity Gopinath et al. 2011a 3,144 Sydney school children Increased BMI Narrower retinal arteriolar 
and wider venular calibre 
Obesity Li et al. 2011 136 Singapore school children (STARS) Increased triceps skinfold and BMI Wider retinal venular calibre 
Cigarette Smoking Liew et al. 2008 15,792 US adults 45-64 years (ARIC) Past cigarette smoking Wider retinal venular calibre 
Cigarette Smoking Rosenburg 2005 Clinical observation Past and current cigarette smoking Clinical retinal venular 
widening 
Cigarette Smoking Jeganathan 2005 Clinical observation Past and current cigarette smoking Clinical retinal venular 
widening 
Medication Thom et al. 2009 19,342 adults 40-79 years undergoing 
antihypertensive therapy (ASCOT) 
Calcium channel blocker vs. β-
blocker therapy 
Less retinal arteriole 
narrowing with calcium 
channel blocker therapy 
Medication Klein et al. 2010 147 adults with type 1 diabetes ACEI and ARB therapy No significant changes 
Air Pollution Adar et al. 2010 6,814 adults 45-84 years (MESA) Higher long- & short-term PM2.5 
exposure 
Narrower retinal arteriolar 
calibre 
 36 
1.15 The Overall Aim of the Proposed Thesis: 
Overall aim of the proposed thesis is: 
(1) To examine select responses in vascular structure (RVC and Df) to twelve weeks 
of controlled and supervised exercise training in women aged 65-74 yr with and 
without uncomplicated type 2 diabetes (no associated peripheral neuropathy, 
nephropathy and/or Peripheral Arterial Disease) when the total exercise time (120 
minutes per week) and relative exercise intensity (Tge: gas exchange threshold) 
are held constant. 
 
Specific aims of the proposed studies are to: 
(1) (Study 1) - Examine the relationship between retinal vessel calibre/fractal 
measurements and measures of physiological functional capacity and endothelial 
function in women aged 65-74 yr with and without uncomplicated type 2 
diabetes. 
(2) (Study 2) - Examine changes in retinal vessel calibre and fractal analysis in 
women aged 65-74 yr with and without uncomplicated type 2 diabetes, following 
twelve weeks of controlled and supervised exercise training at Tge (60-65% VO2 
peak), for a total exercise time of 120 minutes per week. 
(3) (Study 3) - Examine the effects of twelve weeks of controlled and supervised 
exercise training at Tge (60-65% VO2 peak), for a total exercise time of 120 
minutes per week, on plasma ADMA concentration in women aged 65-74 yr 
with uncomplicated type 2 diabetes mellitus.   
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CHAPTER 2 – Study One 
Physiological Functional Capacity and Retinal Microvascular Morphology 
in Women Aged 65-74 Yr with and without Type 2 Diabetes 
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2.1 Introduction  
 
Physiological functional capacity (PFC) has been previously defined as the ability to 
perform the physical tasks of daily life and the ease with which these tasks can be 
performed (Tanaka and Seals 2003). PFC is intended to reflect the central and peripheral 
components that mediate oxygen supply and utilization. Decreased PFC is a well-
established risk factor for cardiovascular disease and all-cause mortality (Tanaka and 
Seals 2003). The health benefits that accompany an increase in peak oxygen uptake 
(VO2peak) are well described (Pate et al. 1995) and include significant beneficial changes 
to endothelial function and to the macrocirculation (Haddock et al. 1998; Kemi et al. 
2004; Lakka et al. 2001). The relationship between measures of PFC and 
microcirculatory function is not as well understood, partly due to the difficulty of 
examining the microcirculation in vivo.    
 
The retinal microvasculature can provide important clinical information on the state of 
the microcirculation in the retina and on the cumulative cerebral and coronary vascular 
damage resulting from aging, hypertension, and other disease processes (Liew et al. 
2007). Given that regular physical activity is well established as an effective means of 
decreasing vascular damage associated with the above conditions, it is reasonable to 
assume that measures of PFC may be associated with the retinal microcirculation. Few 
studies have examined the relationship between measures of PFC and retinal 
microvascular structure. Wider venular calibre has been associated with lower levels of 
physical activity (Anuradha et al. 2011b; Anuradha et al. 2011c; Tikellis et al. 2010) and 
sedentary behaviour in men, but not in women (Anuradha et al. 2011a). In these studies, 
levels of physical activity and inactivity were estimated via self-reported questionnaires. 
To date, the relationship between more direct measures of PFC [including VO2peak, peak 
heart rate, respiratory exchange ratio (RER) and time to exhaustion (TE)] and structure of 
the retinal microcirculation has not been examined. Thus, it is unknown whether 
moderate-intensity exercise has any longitudinal beneficial effects on the retinal 
microcirculation. 
Also, previous studies examining a possible relationship between PFC and microvascular 
structure and function have used RVC as a measure of systemic microvascular structure. 
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Fractal analysis (Df) has recently been used to summarize the geometric complexity of 
retinal vasculature, providing a more “global” and sensitive measure of microvascular 
structure.   
 
The aim of the present study was to determine the relationship between measures of PFC 
and variations in RVC and retinal Df in females aged 65-74 yr with and without 
uncomplicated type 2 diabetes. Appropriately prescribed exercise could improve the 
structure and function of the microvasculature in those persons with and without 
uncomplicated type 2 diabetes. 
 
2.2 Methods 
 
2.2.1 Subjects and Recruitment Strategies 
  
Forty female subjects (19 Type 2 diabetic and 21 non-diabetic), aged 65-74 years 
participated. Subjects were recruited from local GP clinics, media advertisements, and 
mail-outs by Diabetes Australia Queensland. Potential subjects were initially screened by 
telephone interview using a standardized set of questions to determine suitability to enter 
a formal health screening. The following inclusion criteria were used: (i) clinical 
diagnosis of type 2 diabetes for at least 12 months (for type 2 diabetic subjects), (ii) not 
currently using exogenous insulin (iii) non-smoking, (iv) normal age-relative physical 
examination, (v) no severe musculoskeletal disability, and (vi) not currently taking 
medications known to directly interfere with exercise responses (i.e. beta blockers or 
warfarin). All subjects provided written consent to participate. Each subject's cognitive 
capacity to give consent was determined using the Mini-Mental State Examination 
(Folstein et al. 1975) and assessed by an independent observer. During the health-
screening process, height was measured (in millimetres) using a wall-mounted 
stadiometer (Harpenden, Holtain Ltd, Crosswell, UK). Body mass was measured using a 
calibrated digital scale (CH-150k, A & D Pty Ltd, Thebarton, Australia) and waist and 
hip circumference were measured. Pulmonary function was also assessed by 
measurements of forced vital capacity and forced expiratory volume in 1 second using a 
calibrated spirometry system (Ultima CPX, Medical Graphics Corporation, St Paul, 
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USA). Supine and standing 12-lead ECG (Cardio Perfect, Welch Allyn Inc., Skaneateles 
Falls, USA) and blood pressure were measured at rest. 
After an overnight fast, venous blood samples were drawn (between 0700 – 0830 hours) 
at an accredited pathology laboratory for glucose, insulin, HbA1c (for type 2 diabetic 
subjects), low- and high-density lipoprotein cholesterol, triglycerides and homocysteine 
measurements (Appendix E). Subjects were then asked to visit their family physician 
with the health-screening results and details of the experimental procedures for an 
opinion about the suitability of our patient to participate. Bond University Human 
Research Ethics Committee and Griffith University Human Ethics Committee reviewed 
and approved the experimental protocol (RO-745). 
 
2.2.2 Determination of Peak Oxygen Uptake and Gas-Exchange Threshold 
 
Subjects completed an incremental exercise test to volitional fatigue on a motor driven 
treadmill (‘Valiant’; Lode B.V., Groningen, Netherlands) to determine peak oxygen 
uptake (VO2peak), time to exhaustion (TE) and the gas exchange threshold (Tge). Before 
the exercise testing session, subjects were familiarized with treadmill walking at various 
speeds (2.0 – 6.0 km h-1) and treadmill grades (0 – 6%). Each subject’s preferred walking 
speed was determined (at 1% grade). The subject’s preferred walking speed was used 
during all subsequent exercise tests and training sessions. The incremental exercise test 
consisted of a 4-min warm-up at 3.0 km·h-1 and 1% grade, followed by a speed increase 
every minute until the previously determined self-selected walking speed was attained. 
Treadmill grade was then increased by 2% every minute until volitional fatigue or 
clinically significant signs or symptoms precluded further exercise. Cardiac rate and 
rhythm was monitored continuously using a 12-lead ECG and brachial artery blood 
pressure was measured by auscultation every 3 minutes during the incremental exercise 
test. Carbon dioxide output (VCO2), oxygen uptake (VO2), and expired minute 
ventilation (VE BTPS) were measured breath-by-breath and averaged every 30 seconds 
using an open-circuit metabolic measurement system (Ultima CPX, Medical Graphics 
Corporation, St Paul, USA). The gas analysers and pneumotachograph were calibrated 
before and after each incremental exercise test using precision reference gases and an 
independently calibrated 3-L calibration syringe (Hans Rudolph Inc., Kansas City, USA). 
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Peak gas exchange variables (VO2, VCO2) are reported as the average of the two highest 
consecutive 30-second values measured before volitional fatigue. The Tge was determined 
using the simplified V-slope method (Schneider et al. 1993).   
2.2.3 Retinal Photography and Measurement of Retinal Vascular Calibre 
 
After pupil dilation, colour static digital fundus photographs (2 fields of each eye, one 
centred on the optic disk and a second on the macula) were taken using a 45° 6.1 
megapixel digital non-mydriatic camera (Nikon D100, Nikon Corporation, Japan). 
Retinal photographs were taken within 24-48 hours of the incremental exercise test. 
Images were graded by the Retinal Vascular Imaging Centre (RetVIC), Centre for Eye 
Research, Melbourne, Australia for measurements of retinal vascular morphology.  
 
Retinal vascular calibre was measured by trained investigators blinded to participant 
characteristics using a computer-based program (Retinal Analysis, University of 
Wisconsin, Madison, WI, USA) (Liew et al. 2007; Wong et al. 2004b). Briefly, the 
diameter of all arterioles and venules within a concentric zone corresponding to a half- to 
one-disc diameter away from the optic disc margin were measured. Diameters of the 
widest six arterioles and venules were summarized as the central retinal artery equivalent 
(CRAE) and the central retinal venular equivalent (CRVE). CRAE and CRVE represent 
the estimated average calibre of the central retinal artery and vein, respectively 
(Knudtson et al. 2003). Only retinal images from the right eye were analysed.  Intra- and 
inter-grader reproducibility of retinal vascular measurements performed at this site have 
previously been reported, with intra-class correlation coefficients ranging from 0.78 to 
0.99 (Wong et al. 2004b).  The intra-class correlation coefficient for the present study, 
based on re-grading of 20 randomly chosen photographs ranged from 0.79 to 0.98.       
2.2.4 Measurement of Retinal Fractal Dimension 
 
Fractal analysis was completed by trained investigators blinded to participant 
characteristics, using a computer-based program (International Retinal Imaging Software 
[IRIS], National University of Singapore, University of Melbourne, University of 
Sydney; Patent pending), which measured Df (Liew et al. 2008b). Retinal vascular Df of 
each image was calculated within a 3.5-disc radii pre-defined circular area centred on the 
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optic disk. Retinal vessels within this region were automatically traced by the software 
and subsequently examined by investigators to identify and erase artefacts (e.g., peri-
papillary atrophy, choroidal vessels, and pigment abnormalities) that could be mistaken 
by the software as retinal vessels. Fractal analysis was then performed automatically by 
the IRIS software and Df calculated using the box counting approach (Stosic and Stosic 
2006). Reliability of the IRIS measurements was high, with intra-grader intra-class 
correlation coefficients ranging from 0.93 to 0.94. 
 
2.2.5 Statistical Analysis 
 
Results are reported as mean ± standard error unless otherwise stated. An independent t-
test was used to determine difference in means during between group comparisons. 
Bivariate correlations were performed to detect significant relationships between 
dependent variables after adjusting for mean arterial blood pressure (MAP). All statistical 
differences were accepted at the p < 0.05 level. SPSS (SPSS Inc, Release 17.0, USA) was 
used. 
 
2.3 Results 
 
Forty subjects completed the study. One participant with type 2 diabetes was excluded as 
retinal vessel calibre could not be measured in either eye. The descriptive characteristics 
and blood profiles of the subjects are shown in Table 1 and 2. 
 
2.3.1 Age, Blood pressure, and Anthropometric Variables 
 
Subjects with type 2 diabetes had significantly higher body mass, BMI, waist-hip ratio, 
and resting systolic blood pressure when compared to age- and sex-matched non-diabetic 
subjects (Table 1). 
2.3.2 Lipid Profile, Blood Glucose, and Haematology 
 
The concentration of fasting glucose and insulin were significantly higher, and HDL was 
significantly lower, in those subjects with type 2 diabetes (Table 2). Total cholesterol and 
LDL were significantly higher in non-diabetic subjects (Table 2). Total white cell count, 
neutrophil and lymphocyte concentrations were significantly higher in those subjects with 
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type 2 diabetes. There were no significant differences found in any other haematological 
values (Table 3).  
 
2.3.3 Physiological Functional Capacity 
 
Subjects with type 2 diabetes had significantly lower VO2peak, peak heart rate, RER and 
TE. There were no significant differences between the two groups in Tge (expressed as a 
percentage of VO2peak) (Table 4).  
 
2.3.4 Retinal Vessel Calibre and Fractal Analysis 
 
There were no significant differences between groups in CRAE (with diabetes: 153.3±3.8 
µm vs. without diabetes: 154.7±2.7 µm, p = 0.760), CRVE (with diabetes: 220.2±4.4 µm 
vs. without diabetes: 230.8±4.9 µm, p = 0.121), or Df (with diabetes: 1.45 ± 0.004 vs. 
without diabetes: 1.45±0.004, p = 0.595).   
 
2.3.5 Relationships between Retinal Vessel Calibre, Fractal Analysis, and Gas 
 Exchange Data 
 
There were no significant relationships between CRAE or CRVE and any measure of 
PFC (VO2peak, TE, peak RER, peak HR, VEpeak, or Tge) in either group. Df was found 
to be significantly correlated with TE only in those with type 2 diabetes (r = 0.48, p = 0.04) 
(Figure 1). No significant correlations were found between Df and any other measures of 
PFC. 
 
2.4 Discussion 
 
The principal findings of the present study were: (i) no significant differences were found 
between type 2 diabetic and non-diabetic groups in CRAE, CRVE, or Df; and (ii) Df was 
found to be significantly correlated with TE in the type 2 diabetic group. 
 
Non-diabetic subjects in the present study had similar anthropometric characteristics and 
blood profiles as those reported elsewhere (Carvalho et al. 2010; De Vito et al. 1999). 
Individuals with type 2 diabetes displayed significantly higher body mass, BMI, waist-
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hip ratio, resting systolic blood pressure, plasma glucose and insulin concentration 
commonly associated with this disease (American Diabetes Association 2012a). 
Individuals with type 2 diabetes also had significantly increased white cell count and 
neutrophil and lymphocyte concentrations compared to non-diabetic individuals, which 
has been reported elsewhere (Gkrania-Klotsas et al. 2010). While individuals with type 2 
diabetes in the present study had similar anthropometric characteristics to age- and sex-
matched subjects in other studies, cholesterol and LDL levels were significantly lower 
(McGavock et al. 2004; Onisto et al. 2009). Subjects with type 2 diabetes participating in 
the present study were medically well managed, with the majority of subjects also being 
treated for elevated cholesterol. None of the 20 non-diabetic subjects were taking lipid-
lowering medication. The aggressive lipid lowering treatment received by the majority of 
subjects with type 2 diabetes in the present study may explain the lower levels of 
cholesterol and LDL than age- and sex-matched non-diabetic subjects.  
 
Subjects with type 2 diabetes had significantly lower measures of physiological 
functional capacity compared to the non-diabetic group, a well-established consequence 
of type 2 diabetes (Regensteiner et al. 1995). While the exact cause of the decrease in 
PFC that accompanies type 2 diabetes is unknown, it has been suggested that genetically 
determined low mitochondrial number may decrease an individual’s VO2peak (Leite et 
al. 2009). Subjects with type 2 diabetes in our study had similar VO2peak values as age- 
and sex-matched individuals with type 2 diabetes in previous studies (McGavock et al. 
2004; Walker et al. 1999). 
 
No significant differences in retinal vessel calibre or fractal dimension were found in 
subjects with and without type 2 diabetes, which is in contrast to the results of others 
(Wong et al. 2002b; Wong et al. 2005b; Yau et al. 2010). Previous studies found 
individuals with type 2 diabetes had narrower retinal arteriolar diameter (Wong et al. 
2002b; Wong et al. 2005b) and greater retinal Df (Yau et al. 2010) than non-diabetic 
individuals. A possible reason for this difference may be that individuals with type 2 
diabetes participating in our study were medically well-managed and the concomitant 
pharmaceutical interventions may have protected these individuals against significant 
microvascular structural changes. Antihypertensive medication, taken by the majority of 
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the individuals with type 2 diabetes in our study, has previously been shown to have 
beneficial effects on retinal microcirculation (Thom et al. 2009). 
 
No significant relationship was found between any measures of PFC and retinal vessel 
calibre in either cohort.  While no previous studies have investigated the relationship 
between direct measures of PFC and retinal microvascular structure, there is emerging 
evidence that significant relationships are observed between retinal vessel calibre and 
levels of physical activity and sedentary behaviour (Anuradha et al. 2011a; Anuradha et 
al. 2011b; Anuradha et al. 2011c; Tikellis et al. 2010). In the population-based ARIC 
Study, lower levels of self-reported physical activity were significantly associated with 
wider venular calibre (Tikellis et al. 2010). In men, but not women, sedentary behaviour, 
as determined from prolonged television viewing time, was associated with wider venular 
calibre (Anuradha et al. 2011a). There was no significant relationship between self-
reported levels of physical activity and retinal vascular calibre (Anuradha et al. 2011a). 
Lower levels of physical activity were associated with wider retinal venular calibre in the 
Multi-Ethnic Study of Atherosclerosis (Anuradha et al. 2011b). In these studies 
(Anuradha et al. 2011a; Anuradha et al. 2011b; Anuradha et al. 2011c; Tikellis et al. 
2010) physical activity was assessed via a self-report; such methods of determining a 
physical activity history are often inaccurate (Sallis and Saelens 2000). The present study 
assessed PFC by controlled, clinical exercise testing using established methods and 
measurement techniques with known validity and reliability. Studies that have examined 
the relationship between cutaneous microvascular function and direct measures of PFC 
have been inconclusive (Boegli et al. 2003; Lenasi and Strucl 2004; Pasqualini et al. 
2010; Tew et al. 2010; Vassalle et al. 2003). It now appears that only studies examining 
cohorts with large differences in VO2max, showed significant relationships between 
measures of PFC and cutaneous microvascular function (Lenasi and Strucl 2004; 
Pasqualini et al. 2010; Tew et al. 2010; Vassalle et al. 2003). Studies consisting of a 
relatively homogenous cohort with regards to VO2max showed no such relationships 
(Boegli et al. 2003). In our study, participant pool was relatively homogenous with 
regards to measures of PFC in individuals with and without type 2 diabetes, which may 
have masked possible correlations with retinal vessel calibre. Further research may 
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require a larger, more diverse population with regards to measures of PFC to accurately 
assess this relationship. 
 
Prior to our study, the relationships between measures of PFC and Df were unknown. 
Unlike quantifying microvascular structure using retinal vessel diameter, fractal analysis 
allows for a more global measure of retinal vascular pattern and its efficiency in 
circulation (Kamiya and Takahashi 2007; Takahashi et al. 2009). Quantifying retinal 
vascular complexity using retinal fractal dimensions may provide a more accurate and 
sensitive overall estimate of retinal microvascular structure (Liew et al. 2008b). In our 
study, subjects with type 2 diabetes, higher Df was found to be positively correlated with 
time to exhaustion during maximal exercise testing. Df likely provided a more accurate 
measure of retinal microvascular structure than retinal vessel calibre, displaying 
correlations with measures of PFC that may have been masked by a less sensitive 
measure like retinal vessel calibre.  
 
Our study is the first to examine, and show, associations between measures of retinal 
vasculature structure and measures of PFC. At this time we are unable to provide a 
mechanism for the significant relationship between PFC and Df. The beneficial vascular 
adaptations to regular exercise have been shown to be largely mediated by changes in 
vascular structure (Prior et al. 2004), specifically in improvements in endothelial function 
(Vassalle et al. 2003). It has been suggested that changes in retinal microvascular 
structure result from underlying endothelial dysfunction, and may prove to be a effective 
surrogate maker of endothelial function (Liew et al. 2008c). Therefore, exercise-induced 
changes in endothelial function may contribute to the associations between Df and 
measures of PFC in our study. Further research is needed to understand the possible 
differential relationship between Df and measures of PFC in diabetic and non-diabetic 
populations. 
 
In conclusion, we report novel associations between retinal vascular fractal dimension 
and time to exhaustion in women 65-74 years with type 2 diabetes. Further investigation 
involving a larger, more diverse population with regards to VO2peak/max is required to 
determine the relationship between retinal microvascular structure and measures of PFC. 
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Table 1.   Characteristics of participating subjects with and without type 2 diabetes. 
     Mean ± SEM. 
 With Type 2 Diabetes 
(N=19) 
Without Type 2 Diabetes 
 (N=20) 
Subject characteristics   
Age (yr) 68.9±0.78 67.3±0.73 
Body Mass (kg)∗ 76.2±3.4 68.3±1.9 
BMI (kg·m-2)∗ 29.9±1.1 25.9±0.7 
Waist/Hip Ratio∗ 0.85±0.02 0.78±0.02 
SBP (mmHg)∗ 133±3 124±3 
DBP (mmHg) 74±2 73±1 
∗ Significant difference found between individuals with and without type 2 diabetes (p < 0.05) 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
 
 
Table 2.  Blood profiles of participating subjects with and without type 2 diabetes.  
    Mean ± SEM. 
 
 
With Type 2 Diabetes 
 (n=19) 
Without Type 2 Diabetes 
 (n=20) 
Blood Profile   
   Homocysteine (µmol·L-1)   12.1±1.3 10.3±0.7 
Glucose (mmol·L-1)∗ 7.4±0.4 5.1±0.1 
HbA1C (%) 6.6±0.2 N/A 
Insulin (mU·L-1)∗ 10.9±2.2 5.1±0.6 
Cholesterol (mmol·L-1)∗ 4.2±0.2 5.7±0.2 
Triglycerides (mmol·L-1) 1.3±0.1 1.1±0.1 
HDL (mmol·L-1)∗ 1.3±0.1 1.8±0.1 
LDL (mmol·L-1)∗ 2.3±0.2 3.5±0.2 
∗ Significant difference found between individuals with and without type 2 diabetes (p < 0.05) 
HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein. 
 
 
Table 3.   Haematological characteristics of participating subjects with and without type 2 
diabetes. Mean ± SEM. 
 With Type 2 Diabetes 
(n=19) 
Without Type 2 Diabetes 
(n=20) 
Haemoglobin (g·L-1) 129.4±4.1 131.05±1.9 
Haematocrit (%) 40±1 40±1 
Red cell count (1012·L-1)   4.39±0.1 4.37±0.1 
White cell count (109·L-1) ∗ 6.63±0.3 5.25±0.3 
Neutrophils  (109·L-1) ∗ 3.46±0.3 2.69±0.2 
Lymphocytes (109·L-1) ∗ 2.37±0.2 1.88±0.1 
Monocytes (109·L-1) 0.57±0.04 0.48±0.03 
Eosinophils (109·L-1) 0.24±0.1 0.17±0.02 
Basophils (109·L-1) 0.03±0.004 0.03±0.004 
Albumin (g·L-1) 39.5±2.9 42.8±0.6 
∗ Significant difference found between subjects with and without type 2 diabetes (p < 0.05) 
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Table 4.   Gas exchange data for participating subjects with and without type 2 diabetes.  
 Mean ± SEM. 
 With Type 2 Diabetes 
(n=19) 
Without Type 2 Diabetes 
(n=20) 
TE (min) ∗ 13.2±0.7 17.1±0.5 
VO2 peak (L·min-1) ∗ 1.48±0.04 1.64±0.1 
VO2 peak (mL·kg-1·min-1) ∗   20.0±0.9 24.3±1 
Peak HR (b·min-1) ∗ 144±4 159±3 
VE peak(L·min-1) 51.9±2.4 56.8±1 
Tge (%VO2 peak) 70±1 69±1 
Peak RER ∗ 1.1±0.02 1.2±0.02 
∗ Significant difference found between participating subjects with and without type 2 diabetes (p < 0.05) 
TE, time to exhaustion; VO2 peak, peak oxygen uptake; HR, heart rate; VE, ventilation; Tge gas exchange 
threshold; Peak RER, peak respiratory exchange threshold. 
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Figure 1.   Fractal dimension, VO2, and time to exhaustion in participating subjects without (∆) 
and with () type 2 diabetes.  R is the Pearson product–moment correlation 
coefficient.  
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3.1 Introduction 
 
Increased risk of cardiovascular disease and microvascular dysfunction are well-
established co-morbidities of type 2 diabetes. While numerous pharmacologic agents 
have been shown to effectively moderate cardiovascular disease risk associated with type 
2 diabetes, lifestyle modification, including regular exercise, remains an effective 
therapeutic intervention for individuals with type 2 diabetes (Marwick et al. 2009). 
Regular exercise is effective in improving macrovascular endothelial function in persons 
with type 2 diabetes (Maiorana et al. 2001) and in older individuals (DeSouza et al. 
2000). A few studies have investigated and reported the effects of repeated bouts of 
exercise on cutaneous microvascular structure (Black et al. 2008; Goto et al. 2003; 
Hamdy et al. 2003; Hodges et al. 2010; Middlebrooke et al. 2006; Wang 2005). Findings 
from these studies are inconsistent, with an apparent intensity dependent effect of aerobic 
exercise on microvascular structure.     
 
Disturbances in microvascular function have an important role in the pathophysiology of 
type 2 diabetes and may also explain part of the excess cardiovascular disease risk in type 
2 diabetes (Tooke 1995). The retinal microvasculature, accessible by direct non-invasive 
visualization, has recently garnered interest as a site for assessing the systemic 
microcirculation in vivo (Liew et al. 2008c). Significant associations are reported 
between changes in the retinal microvasculature and both clinical and subclinical 
cardiovascular (Wang et al. 2006a) and metabolic diseases (Nguyen and Wong 2006). 
Specifically, changes in retinal arteriolar and venular microvascular calibre have been 
associated with both macro and microvascular complications in type 2 diabetics (Klein et 
al. 2007).    
 
Few studies have examined the effect of physical activity on retinal microvascular 
changes. Wider venular calibre has been associated with lower levels of physical activity 
(Anuradha et al. 2011b; Anuradha et al. 2011c; Tikellis et al. 2010) and sedentary 
behaviour in men, but not women (Anuradha et al. 2011a). However, these studies 
examined only mild levels of physical activity and inactivity (via self-reported 
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questionnaires) and used a cross-sectional design. Thus, it is unknown whether moderate-
intensity exercise has longitudinal beneficial effects on the retinal vasculature. 
 
No studies have yet examined the effects of repeated bouts of moderate-intensity exercise 
on retinal microvascular morphology. The aim of the present study was to investigate the 
effect of 12-weeks of supervised, moderate-intensity walking exercise on retinal vascular 
morphology, including vessel calibre and vascular fractal dimension in women 65-74 
years of age with type 2 diabetes.  
 
3.2 Patients and Methods 
 
3.2.1 Subjects and Recruitment Strategies  
 
Fifteen women with type 2 diabetes, aged 65-74 years participated. Subjects were 
recruited from local family medical clinics, and after media advertisements and mail-outs 
by Diabetes Australia Queensland. Recruitment was difficult from this age group. 
Approximately 5,000 flyers were distributed to local GP clinics, diabetes educators, 
hospitals and pharmacies. Newspaper and radio advertisements were run weekly over a 
6-month period. From patient databases and all contacts, approximately 500 potential 
subjects meeting all eligibility criteria were contacted via mail with help from Diabetes 
Australia Queensland. After 18 months of extensive recruitment, only 72 persons (14% of 
those invited) expressed interest in participating, of whom 32 withdrew because of the 
time commitment needed or because of unwillingness to exercise. After excluding those 
who did not meet our inclusion criteria, there was a cohort of 16 persons, with only 15 
persons completing all repeated testing periods (wk -6, 0, 6, 12) and exercise-training 
sessions.   
 
Potential subjects were initially screened by telephone interview using a standardized set 
of questions to determine suitability to enter a formal health screening. The following 
inclusion criteria were used: (i) clinical diagnosis of type 2 diabetes for at least 12 
months, (ii) not currently using exogenous insulin (iii) non-smoking, (iv) normal age-
relative physical examination, (v) no significant abnormalities in heart rate and rhythm 
during a graded treadmill exercise test, (vi) no severe musculoskeletal disability, and (vii) 
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not currently taking medications known to directly interfere with exercise responses. All 
subjects provided written consent to participate. Each subject's cognitive capacity to give 
consent was determined using the Mini-Mental State Examination (Folstein et al. 1975) 
and assessed by an independent observer. Subjects then entered a formal health-screening 
phase that included anthropometry and pulmonary function testing. Height was measured 
(in millimetres) using a wall-mounted stadiometer (Harpenden, Holtain Ltd, Crosswell, 
UK). Body mass was measured using a calibrated digital scale (CH-150k, A & D Pty Ltd, 
Thebarton, Australia) and waist and hip circumference were measured. Pulmonary 
function was assessed (forced vital capacity, forced expiratory volume in 1 second, and 
forced expiratory volume in 1 second/forced vital capacity ratio) using a calibrated 
spirometry system (Ultima CPX, Medical Graphics Corporation, St Paul, USA). Supine 
and standing 12-lead ECG (Cardio Perfect, Welch Allyn Inc., Skaneateles Falls, USA) 
and blood pressure were measured at rest. 
 
After an overnight fast, venous blood samples were drawn (between 0700 – 0830 hours) 
at an accredited pathology laboratory for glucose, insulin, haemoglobin A1c (HbA1c), low- 
and high-density lipoprotein cholesterol, triglycerides and homocysteine measurements 
(Appendix E). Subjects were then asked to visit their family physician with the health-
screening results and details of the experimental procedures for an opinion about their 
suitability to participate. Bond University Human Research Ethics Committee and 
Griffith University Human Ethics Committee reviewed and approved the experimental 
protocol (RO-745). 
 
3.2.2 Determination of Peak Oxygen Uptake and Gas-Exchange Threshold 
 
Prior to determining peak oxygen uptake, all subjects were thoroughly familiarized with 
all intended procedures and equipment. Subjects then completed an incremental exercise 
test to volitional fatigue on a motor driven treadmill (‘Valiant’; Lode B.V., Groningen, 
Netherlands) to determine VO2peak, TE and Tge. Before the first exercise testing session, 
subjects were familiarized with treadmill walking at various speeds (2.0 – 6.0 km h-1) and 
treadmill grades (0 – 10%). Each subject’s preferred walking speed was determined (at 
1% grade). This was used as the treadmill speed during all subsequent exercise tests and 
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training sessions. The incremental exercise test consisted of a 4-min warm-up at 3.0 
km·h-1 and 1% grade, followed by a speed increase every minute until the previously 
determined self-selected speed was attained. Treadmill grade was then increased by 2% 
every minute until volitional fatigue or clinically significant signs or symptoms precluded 
further exercise. Cardiac rate and rhythm was monitored continuously using a 12 lead 
ECG and brachial artery blood pressure was measured by auscultation every 3 minutes 
during the incremental exercise test. VCO2, VO2, and VE BTPS were measured breath-
by-breath and averaged every 30 seconds using an open-circuit metabolic measurement 
system (Ultima CPX, Medical Graphics Corporation, St Paul, USA). The gas analysers 
and pneumotachograph were calibrated before and after each incremental exercise test 
using precision reference gases and an independently calibrated 3-L calibration syringe 
(Hans Rudolph Inc., Kansas City, USA). The average of the two highest consecutive 30-
second values measured before volitional fatigue was used to determine peak gas 
exchange (VO2, VCO2) values. 
 
3.2.3 Exercise Training Program 
 
After recruitment, dependent variables were measured 6 weeks before commencing 
exercise training (acting as a control period for each subject) (wk -6), immediately before 
starting the exercise training program (wk 0), and after 6- and 12-weeks exercise training.  
All subjects exercised by walking on a motor driven treadmill for a total of 120 
minute·week-1, at an intensity equivalent to their individual Tge. Before commencing 
exercise training (wk 0), subjects were again familiarized with walking on a motor-driven 
treadmill. Subjects completed a 3-minute warm-up and a 3-minute cool-down at 3km·hr-1 
and 1% grade for all exercise training sessions. Before each exercise training session, 
subjects were fitted with a 5-lead ECG X12+ (Mortara Instrument Inc., Milwaukee, 
USA) to monitor heart rate and rhythm continuously. Heart rate and blood pressure were 
recorded every 5 minutes throughout all exercise training sessions.   
 
Exercise training intensity was individually determined during the first training session 
using breath-by-breath open-circuit spirometry to determine VO2. While at each subject's 
self-selected walking speed, treadmill grade was increased 1% every 3 minutes until 
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steady-state VO2 matched their pre-determined Tge. Based on maximal exercise test 
results obtained after 6 weeks of exercise training (wk 0-6), exercise intensity was 
adjusted to maintain the same relative percent (100%) of Tge for the remaining 6 weeks of 
exercise training. Subjects were instructed to continue their normal daily activities during 
both the 6-week control period and 12-week exercise-training program. 
 
3.2.4 Retinal Photography and Measurement of Retinal Vascular Calibre 
 
After pupil dilation, colour static digital fundus photographs (2 fields of each eye, one 
centred on the optic disk and a second on the macula) were taken using a 45° 6.1 
megapixel digital non-mydriatic camera (Nikon D100, Nikon Corporation, Japan). 
Retinal photographs were taken within 24-48 hours of the last exercise session during the 
intervention period (wk 6 and 12). Images were graded by the Retinal Vascular Imaging 
Centre (RetVIC), Centre for Eye Research, Melbourne, Australia for measurements of 
retinal vascular morphology.  
 
RVC was measured by trained graders masked to participant characteristics using a 
computer-based program (Retinal Analysis, University of Wisconsin, Madison, WI, 
USA) (Wong et al. 2004b). Briefly, the diameter of all arterioles and venules within a 
concentric zone corresponding to a half- to one-disc diameter away from the optic disc 
margin were measured. Diameters of the widest six arterioles and venules were 
summarized as central retinal artery equivalent (CRAE) and central retinal vein 
equivalent (CRVE). CRAE and CRVE represent the estimated average calibre of the 
central retinal artery and vein, respectively (Wong et al. 2004b). The AVR was calculated 
as CRAE divided by CRVE. Retinal images from the right eye were analysed.  Intra- and 
inter-grader reproducibility of retinal vascular measurements are previously reported, 
with the intra-class correlation coefficients between 0.78 and 0.99 (Wong et al. 2004b).  
The intra-class correlation for the present study, based on re-grading of 20 randomly 
chosen photographs was confirmed and ranged from 0.79 to 0.98.    
 
3.2.5 Measurement of Retinal Fractal Dimension 
 
Fractal analysis was completed by trained graders, masked to participant characteristics, 
using a computer-based program (International Retinal Imaging Software [IRIS], 
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National University of Singapore, University of Melbourne, University of Sydney; Patent 
pending), which measured Df (Liew et al. 2008b). Retinal vascular Df of each image was 
calculated within a 3.5-disc radii pre-defined circular area centred on the optic disk. 
Retinal vessels within this region were automatically traced by the software and 
subsequently examined by graders to identify and erase artefacts (e.g., peripapillary 
atrophy, choroidal vessels, and pigment abnormalities) that could be mistaken by the 
software as retinal vessels. Fractal analysis was then performed by the IRIS software and 
Df calculated using a pre-established box counting approach (Liew et al. 2008b). 
Reliability of the IRIS measurements was high, with intra-grader intra-class correlation 
coefficients ranging from 0.93 to 0.94. 
 
3.2.6 Statistical Analysis 
 
Results are reported as mean ± standard error unless otherwise stated. Data were analysed 
after adjusting for mean arterial blood pressure (MAP) using a repeated measures 
analysis of variance with exercise group as the between-subject variable, and weeks (wk 
0, 6, 12) as the within-subject variable. All statistical differences were accepted at the p < 
0.05 level. SPSS (SPSS Inc, Release 17.0, USA) was used. 
 
3.3 Results 
  
No significant differences were detected in any dependent variable before or after the 6-
week (wk -6 to 0) intervention-free control period (Table 1). 
 
After 6 and 12-weeks of exercise training, there were no significant changes in body 
mass, BMI or waist-to-hip ratio. However, both systolic (p = 0.014) (Figure 1) and 
diastolic (p = 0.032) (Figure 1) blood pressure were significantly reduced after 12-weeks 
of exercise training, as was HDL (p = 0.035). No significant changes were found in other 
blood or lipid profile measurements after 12-weeks of exercise training. 
 
Twelve weeks of exercise training at an intensity equivalent to Tge (72-74 % VO2peak) 
resulted in significant increases in time to exhaustion (p < 0.001), VO2peak (p = 0.016), 
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VO2 at Tge (p = 0.030), and heart rate at Tge (p = 0.033), VO2peak relative to body mass 
(p = 0.026) (Figure 2), and peak respiratory exchange ratio (p = 0.040). 
 
Using MAP as a covariate, no significant changes were found in CRAE (p = 0.464), 
CRVE (p = 0.519), or AVR (p = 0.879) after 6 and 12-weeks exercise training (Table 2, 
Figure 3). Retinal fractal dimension (Df) (p = 0.284) was also unchanged after 6- and 12-
weeks of exercise training (Table 2, Figure 3).  
 
3.4 Discussion 
 
Our study found that 12-weeks of moderate-intensity exercise training (120 minutes per 
week at an intensity equivalent to individual Tge) did not significantly alter RVC or 
retinal Df in women aged 65-74 years with type 2 diabetes. Although RVC may have 
changed immediately after each exercise training session due to increases in blood flow 
associated with exercise, any such changes in the retinal microvasculature must have 
been short lived. Twelve weeks of exercise training, did result in significant increases in 
HDL, exercise time to exhaustion, absolute and relative VO2peak, Tge and significant 
decreases in systolic and diastolic blood pressure. 
 
Subjects in the present study had similar anthropometric characteristics and responses to 
exercise as those reported in other studies of older women with type 2 diabetes 
(McGavock et al. 2004). Despite exercising for 120 minutes/week, 12-weeks of 
moderate-intensity exercise training did not decrease BMI, body mass, or waist-to-hip 
ratio, consistent with previous studies (Middlebrooke et al. 2006). The lack of 
improvement in BMI, waist-to-hip ratio and body mass may reflect the short duration of 
the exercise training program, and any decreases in fat mass could be offset by initial 
increases in muscle mass. In agreement with our study, moderate intensity, aerobic 
exercise has been effective in improving VO2peak and time to exhaustion (McGavock et 
al. 2004). In a study of post-menopausal women, aged 51-67 years with type 2 diabetes, 
10 weeks of cycle ergometry, 3 times / week for 55 minutes per session at 75% of heart 
rate reserve (HRR) resulted in a 15% increase in VO2peak (McGavock et al. 2004). In 
our study, the increase in VO2peak was approximately 9%, possibly explained by the 
shorter weekly exercise duration (120 vs. 165 minutes) and the older age of the women.  
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Studies available for comparison have examined changes in retinal vascular calibre 
associated with diseases involving macrovascular endothelial dysfunction, including 
coronary heart disease (Wong et al. 2002a), hypertension (Wong et al. 2005b), heart 
failure (Wong et al. 2005a), and type 1 and type 2 diabetes (Nguyen et al. 2008; Wong et 
al. 2002b). While evidence supporting the effectiveness of exercise training in improving 
macrovascular function is well documented and consistent (Haddock et al. 1998; Woolf 
et al. 2008), the evidence is limited and inconsistent with regards to exercise-related 
changes in microvascular function (Black et al. 2008; Goto et al. 2003; Hamdy et al. 
2003; Hodges et al. 2010; Middlebrooke et al. 2006; Wang 2005). 
 
Prior to our study, most research examining the effects of exercise training on human 
microvasculature has focused on cutaneous microvessels (Black et al. 2008; Goto et al. 
2003; Hamdy et al. 2003; Hodges et al. 2010; Middlebrooke et al. 2006; Wang 2005). 
This vascular bed, like retinal microvessels (Wong et al. 2006), has been shown to reflect 
generalized microvascular function (Holowatz et al. 2008) and may function as a measure 
of pre-clinical microvascular disease. In individuals with microvascular dysfunction 
associated with type 2 diabetes, effects of exercise training on cutaneous microvascular 
function have been examined (Black et al. 2008; Goto et al. 2003; Hamdy et al. 2003; 
Hodges et al. 2010; Middlebrooke et al. 2006; Wang 2005). Among individuals with type 
2 diabetes (Middlebrooke et al. 2006), or obese individuals with insulin-resistance 
syndrome (Hamdy et al. 2003), regular exercise did not significantly improve 
microvascular function as measured by cutaneous reactivity. Furthermore, after a 6-
month exercise-training program (at 70-80% of maximal heart rate) for people with type 
2 diabetes (Middlebrooke et al. 2006), there was no significant improvement in 
microvascular function or in measures of “aerobic fitness”, raising concern about the 
effectiveness of the selected exercise training stimulus. Our study, together with work by 
Hamdy et al. (Hamdy et al. 2003), report no significant improvements in microvascular 
structure with exercise training, despite increases in VO2peak and related measures. 
Hamdy et al. (Hamdy et al. 2003) reported a significant increase in macrovascular 
endothelial function, but no cutaneous microvascular function change following 6 months 
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of weight reduction and exercise training in obese persons aged 30-65 years with insulin-
resistance syndrome. 
 
Improvements in microvascular function with aerobic exercise have been reported (Black 
et al. 2008; Wang 2005), but with an apparent intensity dependent effect.  Moderate-
intensity (50% VO2peak) aerobic exercise, as opposed to low (< 25% VO2peak) and high 
intensity (> 75% VO2peak) aerobic exercise, has been shown to improve cutaneous 
microvascular function in healthy adults after 8 weeks of exercise training (Wang 2005).  
Moderate-intensity exercise training for 24 weeks was found to prevent the decline in 
microvascular nitric oxide-mediated vasodilator function in older, healthy individuals 
(Black et al. 2008).  Differences in exercise intensity reported in other studies (Black et 
al. 2008; Wang 2005) and in our study could explain why no significant changes were 
observed in the retinal microvasculature. 
 
In the present study, exercise training intensity averaged approximately 72% VO2peak, 
bordering on high-intensity exercise.  It has been suggested that relatively “mild 
intensity” (< 25% VO2peak) and “high intensity” (> 75% VO2peak) aerobic exercise may 
not elicit changes in microvascular function (Goto et al. 2003), possibly explaining in 
part the results of our study. Goto et al. (Goto et al. 2003) found that 12-weeks of “mild 
intensity” and “high intensity” aerobic exercise did not significantly improve 
microvascular endothelial function in young men, while individuals exercising at 
“moderate” intensity (50% VO2peak) showed significant improvements in microvascular 
function. The authors suggested that low-intensity exercise may be an insufficient 
stimulus for improvement, while high-intensity exercise may impair endothelium-
dependent vasodilation by reducing nitric oxide bio-availability through decreased 
antioxidant levels and increases in reactive oxygen species (Goto et al. 2003). Subjects in 
our study could have been exercising at an intensity (72% VO2peak) that impaired 
endothelium-dependent vasodilation, thereby preventing improvements in retinal 
microvascular structure.  
 
A recent study strengthened the results of Goto et al (Goto et al. 2003). Hodges et al. 
(Hodges et al. 2010) found that in post-menopausal women, 48 weeks mild-intensity (< 
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45% HRR) exercise training was associated with improved cutaneous vascular function. 
Significant increases in cutaneous vascular conductance occurred during the first 24 
weeks of mild-intensity exercise. After this period, increases in the intensity of exercise 
training to 60 and 75 % of HRR did not elicit further significant improvements in 
cutaneous vascular function, despite increases in VO2peak. That exercise intensity can 
differentially affect microvascular function has important implications for people who 
select exercise as a therapeutic intervention to manage chronic diseases, such as type 2 
diabetes. 
 
Few studies have examined potential associations between retinal vascular morphology 
and physical activity (Anuradha et al. 2011a; Anuradha et al. 2011b; Anuradha et al. 
2011c; Tikellis et al. 2010). Higher levels of physical activity during sport and work were 
significantly associated with wider venular calibre in the ARIC Study (Tikellis et al. 
2010). In the Multi-Ethnic Study of Atherosclerosis, lower levels of physical activity 
were associated with wider retinal venular calibre in non-Hispanic whites and Hispanics, 
but not in Blacks or Chinese (Anuradha et al. 2011b). Anuradha et al. (Anuradha et al. 
2011a) found no significant relationship between physical activity (self-reported 
questionnaire) and retinal vascular calibre. However, in men, but not women, sedentary 
behaviour (as measured by television viewing time) was associated with wider venular 
calibre (Anuradha et al. 2011a).  While small cross-sectional influences of mild physical 
activity on retinal vascular structure have been reported, longitudinal studies using 
exercise of higher intensity would be needed for direct comparison to the present study.    
 
Many subjects in our study were taking antihypertensive and/or lipid-lowering 
medications, which could have improved vascular function to a point where 12-weeks of 
exercise training may have provided no further benefit. More likely, 12-weeks exercise 
training may have been too short a duration to demonstrate significant improvements in 
retinal vascular morphology.  The autoregulation of hemodynamics in the retinal 
vasculature, particularly in arterioles, may have also contributed to the non-significant 
findings (Pournaras et al. 2008).  
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Subject recruitment posed difficulty because of the significant time requirements of the 
exercise training program and the use of a repeated measure design. Most in our cohort 
were relatively healthy, active and had reasonable diabetic control, so that further 
significant improvements in microvascular morphology with exercise could be more 
difficult in these subjects than in others.  
 
In conclusion, the present study suggests that in women aged 65-74 years with type 2 
diabetes, 12-weeks moderate-intensity exercise training (walking) did not significantly 
affect retinal microvascular structure reflected by measures of retinal vascular calibre and 
fractal dimension. Further investigation with a longer duration of exercise and a range of 
exercise intensities may help to determine the effectiveness of repeated bouts of exercise 
training on the retinal microcirculation. 
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Table 1. Clinical characteristics of participating subjects before (wk -6) and after (wk 0) 6-week     
intervention-free control period. Mean ± SEM. 
 Week -6 (n=15) Week 0 (n=15) 
Age (years) 68.9±0.7 68.9±0.7 
Body Mass (kg) 77.1±3.5 76.5±3.6 
BMI (kg·m-2) 30.1±1.3 29.9±1.3 
Waist/Hip Ratio  0.86±0.02 0.85±0.02 
Blood Pressure (mmHg)   
SBPrest  133±3 127±2 
DBPrest 76±2 74±2 
Blood Profile   
Homocysteine (µmol·L-1) 12.3±1.3 12.1±1.3 
Glucose (mmol·L-1) 7.3±0.4 7.3±0.5 
HbA1C (%) 6.6±0.2 6.6±0.2 
Insulin (mU·L-1) 11.1±2.2 10.9±2.2 
Lipid Profiles (mmol·L-1)   
Total Cholesterol  3.4±0.2 3.3±0.2 
Triglycerides  1.4±0.2 1.3±0.1 
HDL 1.4±0.1 1.4±0.1 
LDL  2.4±0.2 2.4±0.2 
Exercise Responses   
TE (min) 13.8±0.6 13.9±0.5 
VO2peak (L·min-1) 1.52±0.04 1.48±0.05 
VO2peak (mL·kg-1·min-1) 20.2±0.8 19.7±1 
Peak HR (b·min-1) 144±3 141±4 
VE peak (L·min-1) 53.1±1.9 51.9±2.4 
VO2Tge (L·min-1) 1.1±0.2 1.0±0.2 
Peak RER 1.09±0.02 1.10±0.02 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated 
haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TE, time to exhaustion; 
VO2peak, peak oxygen uptake; HR, heart rate; VE, ventilation; VO2 Tge, oxygen uptake at gas-exchange 
threshold; RER, respiratory exchange ratio. 
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Table 2. Retinal vessel measurements of participating subjects by week (-6,0,6,12).  
  Mean ± SEM. 
 
Week -6 
(n=15) 
Week 0 
(n=15) 
Week 6 
(n=15) 
Week 12 
(n=15) 
CRAE (µm) 148±6 149±6 148±6 146±7 
CVRE (µm) 213±5 215±4 216±6 216±6 
AVR 0.70±0.01 0.70±0.02 0.70±0.02 0.70±0.02 
Fractal Dimension (Df)  1.46±0.01 1.46±0.01 1.45±0.01 1.45±0.01 
CRAE, central retinal artery equivalent; CRVE, central retinal venular equivalent; AVR, artery-to-venule 
ratio. 
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Figure 1.   Changes in systolic blood pressure () and diastolic blood pressure () during 6-
week control period (wk -6 to wk 0), and after 6 and 12-weeks of exercise training 
(wk 0 to wk 6 to wk 12). Mean ± SEM.  *, p < 0.05, significantly different to pre-
training (wk 0). 
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Figure 2.   (A) Changes in peak VO2 (), (B) VO2 at Tge (), (C) time to exhaustion (TE) (X) 
during 6-week control period (wk -6 to wk 0), and after 6 and 12-weeks of exercise 
training (wk 0 to wk 6 to wk 12).  Mean ± SEM.  *, p < 0.05, significantly different to 
pre-training (wk 0). 
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Figure 3.   (A) Changes in CRAE
 
(), (B) CRVE
 
(), (C) AVR (X), and (D) Df () during 6-
week control period (wk -6 to wk 0), and after 6 and 12-weeks of exercise training 
(wk 0 to wk 6 to wk 12).  Mean ± SEM.  
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CHAPTER 4 – Study Three 
Effect of Exercise Training on Asymmetric Dimethylarginine Concentration 
in Women Aged 65-74 Yr with Type 2 Diabetes 
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4.1 Introduction 
Type 2 diabetes is associated with a two-to-three fold higher incidence of macrovascular 
atherosclerotic disease compared to non-diabetic individuals (Kannel and McGee 1979). 
The increased incidence of microvascular atherosclerotic disease cannot be fully 
explained by the presence of conventional risk factors such as hypertension, obesity, and 
dislypidaemia (Yamagishi and Imaizumi 2005), that often accompany diabetes. 
Decreased NO bioavailability, a key modulator of endothelial function, may contribute to 
the development of the microvascular complications associated with type 2 diabetes 
(Schalkwijk and Stehouwer 2005), which is in part modulated by ADMA (Kawata et al. 
2005; Lin et al. 2002).  
 
ADMA is an endogenous, competitive inhibitor of NO synthase and a known 
independent cardiovascular risk factor (Vallance et al. 1992a; Vallance and Leiper 2004). 
Plasma ADMA concentrations have been shown to be elevated in individuals with 
increased cardiovascular risk (Boger et al. 1998; Schnabel et al. 2005; Surdacki et al. 
1999; Vallance et al. 1992b), older individuals (Miyazaki et al. 1999), and in patients 
with type 2 diabetes (Abbasi et al. 2001; Kawata et al. 2005; Lin et al. 2002). Elevated 
plasma ADMA concentrations are thought to play a role in the endothelial dysfunction 
and associated vascular complications seen in individuals with type 2 diabetes (de Jager 
et al. 2006; Malecki et al. 2007; Yamagishi et al. 2008). While regular physical exercise 
has been shown to improve endothelial function in individuals with type 2 diabetes 
(Maiorana et al. 2001; Okada et al. 2010), the pathophysiological basis for these exercise-
induced improvements remains unclear.  
 
Regular physical exercise has been shown to reduce circulating levels of ADMA in 
patients with increased risk of coronary heart disease (Richter et al. 2005), in patients 
with metabolic syndrome (Gomes et al. 2008) and type 1 diabetes mellitus (Mittermayer 
et al. 2005). To date, no study has examined the effects of repeated bouts of moderate-
intensity exercise on ADMA concentration in individuals with type 2 diabetes. Therefore, 
the aim of the present study was to determine the effects of 12-weeks of moderate-
intensity exercise on plasma ADMA in women 65-74 years of age with type 2 diabetes. 
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4.2 Methods 
 
4.2.1 Participants and Recruitment Strategies 
  
Fifteen women with type 2 diabetes, aged 65-74 years participated. Participants were 
recruited from local GP clinics, media advertisements and mail-outs by Diabetes 
Australia Queensland. Recruitment was difficult from this age group. Approximately 
5,000 flyers were distributed to local GP clinics, diabetes educators, hospitals and 
pharmacies. Newspaper and radio advertisements were run weekly over a 6-month 
period. From patient databases and all contacts, approximately 500 potential participants 
meeting all eligibility criteria were contacted via mail with help from Diabetes Australia 
Queensland. After 18 months of extensive recruitment, only 72 persons (14% of those 
invited) expressed interest in participating, of which 32 withdrew because of the time 
commitment needed or because of their unwillingness to exercise. After excluding those 
who did not meet our inclusion criteria, there was a cohort of 16 persons; with only 15 
persons completing all repeated testing periods (wk -6, 0, 6, 12) and all exercise-training 
sessions.   
 
Potential participants were initially screened by telephone interview using a standardized 
set of questions to determine suitability to enter a formal health screening. The following 
inclusion criteria were used: (i) clinical diagnosis of type 2 diabetes for at least 12 
months, (ii) not currently using exogenous insulin (iii) non-smoking, (iv) normal age-
relative physical examination, (v) no significant abnormalities in heart rate and rhythm 
during a graded treadmill exercise test, (vi) no severe musculoskeletal disability and (vii) 
not currently taking medications known to directly interfere with exercise responses. All 
participants provided written consent to participate. Each subject's cognitive capacity to 
give consent was determined using the Mini-Mental State Examination (Folstein et al. 
1975) and assessed by an independent observer. Participants then entered a formal health-
screening phase that included anthropometry and pulmonary function testing. Height was 
measured (in millimetres) using a wall-mounted stadiometer (Harpenden, Holtain Ltd, 
Crosswell, UK). Body mass was measured using a calibrated digital scale (CH-150k, A & 
D Pty Ltd, Thebarton, Australia) and waist and hip circumference were measured. 
Pulmonary function was assessed (forced vital capacity, forced expiratory volume in 1 
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second, and forced expiratory volume in 1 second/forced vital capacity ratio) using a 
calibrated spirometry system (Ultima CPX, Medical Graphics Corporation, St Paul, 
USA). Supine and standing 12-lead ECG (Cardio Perfect, Welch Allyn Inc., Skaneateles 
Falls, USA) and blood pressure were measured at rest. 
 
After an overnight fast, venous blood samples were drawn (between 0700 – 0830 hours) 
at an accredited pathology laboratory for measurements of glucose, insulin, haemoglobin 
A1c (HbA1c), and homocysteine concentrations (Appendix E). Participants were then 
asked to visit their family physician with the health-screening results and details of the 
experimental procedures for an opinion about their suitability to participate in the 
exercise training program. Bond University Human Research Ethics Committee and 
Griffith University Human Ethics Committee reviewed and approved the experimental 
protocol (RO-745). 
 
4.2.2 Determination of Peak Oxygen Uptake and Gas-Exchange Threshold  
 
Prior to determining peak oxygen uptake, all participants were thoroughly familiarized 
with all procedures and equipment. Participants then completed an incremental exercise 
test to volitional fatigue on a motor driven treadmill (‘Valiant’; Lode B.V., Groningen, 
Netherlands) to determine VO2peak, TE and Tge. Before the first exercise testing session, 
participants were familiarized with treadmill walking at various speeds (2.0 – 6.0 km h-1) 
and treadmill grades (0 – 10%). Each subject’s preferred walking speed was determined 
(at 1% grade). Preferred walking speed was used as the treadmill speed during all 
subsequent exercise tests and exercise training sessions. The incremental exercise test 
consisted of a 4-min warm-up at 3.0 km·h-1 and 1% grade, followed by a speed increase 
every minute until the previously determined preferred walking speed was attained. 
Treadmill grade was then increased by 2% every minute until volitional fatigue or 
clinically significant signs or symptoms precluded further exercise. Cardiac rate and 
rhythm was monitored continuously using a 12 lead ECG and brachial artery blood 
pressure was measured by auscultation every 3 minutes during the incremental exercise 
test. VCO2, VO2, and VE BTPS were measured breath-by-breath and averaged every 30 
seconds using an open-circuit metabolic measurement system (Ultima CPX, Medical 
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Graphics Corporation, St Paul, USA). The gas analysers and pneumotachograph were 
calibrated before and after each incremental exercise test using precision reference gases 
and an independently calibrated 3-L calibration syringe (Hans Rudolph Inc., Kansas City, 
USA). The average of the two highest consecutive 30-second values measured before 
volitional fatigue was used to determine peak gas exchange (VO2, VCO2) values. Tge was 
determined using the simplified V-slope method (Schneider et al. 1993).   
 
4.2.3 Exercise Training Program 
 
After recruitment, dependent variables were measured 6 weeks before commencing 
exercise training (acting as a control period for each subject) (wk -6), immediately before 
starting the exercise training program (wk 0), and after 6 and 12-weeks of exercise 
training.  All participants exercised by walking on a motor driven treadmill for a total of 
120 minute·week-1, at an intensity equivalent to their individual Tge. Before commencing 
exercise training (wk 0), participants were again familiarized with walking on a motor-
driven treadmill. Participants completed a 3-minute warm-up and a 3-minute cool-down 
at 3km·hr-1 and 1% grade for all exercise training sessions. Before each exercise training 
session, participants were fitted with a 5-lead ECG X12+ (Mortara Instrument Inc., 
Milwaukee, USA) to continuously monitor heart rate and rhythm. Heart rate and blood 
pressure were recorded every 5 minutes throughout all exercise training sessions.   
 
Exercise training intensity was individually determined during the first exercise training 
session using breath-by-breath open-circuit spirometry, to determine VO2. While at each 
subject's preferred walking speed, treadmill grade was increased 1% every 3 minutes 
until steady-state VO2 matched their pre-determined Tge. Based on maximal exercise test 
results obtained after 6 weeks of exercise training (wk 0-6), exercise intensity was 
adjusted to maintain the same relative percent (100%) of Tge for the remaining 6 weeks 
exercise training. Participants were instructed to continue their normal daily activities 
during both the 6-week control period and 12-week exercise-training program. 
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4.2.4 Determination of Asymmetric Dimethylarginine 
 
Blood was collected from a prominent antecubital vein into ethylenediaminetetraacetic 
acid (EDTA) blood collection tubes, which were immediately placed on a tube roller. 
Plasma was separated from whole blood within 30 min of collection and subsequently 
stored at -80 °C until analysed.  ADMA concentrations were assayed (in fasting plasma) 
using a commercially available enzyme-linked immunosorbent assay (ELISA) kit 
(Immundiagnostik AG, Bensheim, Germany). A Fluido microplate strip-washer (Anthos 
Labtec Instruments, Eugendorf, Austria) and Anthos 2020 absorbance reader (Anthos 
Labtec Instruments, Eugendorf, Austria) were utilized during all assays. The ELISA kit 
reported a sensitivity of 0.05 µmol·L-1.  The intra-assay coefficient of variation ranged 
from 5.3-7.7%. Standards and controls provided with the kits were used in measurements.  
 
4.2.5 Statistical Analysis 
 
Results are reported as mean ± standard error unless otherwise stated. Data were analysed 
using a mixed design analysis of variance (ANOVA) with exercise group as the between-
subject variable, and weeks (wk 0, 6, 12) as the within-subject variable. All statistical 
differences were accepted at the p < 0.05 level. SPSS (SPSS Inc, Release 17.0, USA) was 
used for all statistical analyses. 
 
4.3 Results  
 
Of the fifteen individuals who started the exercise training program, fourteen individuals 
completed all repeated testing periods, blood draws, and exercise training sessions. No 
significant differences were found in any dependent variables before or after the 6-week 
intervention-free control period (wk -6 to 0) (Table 1). 
 
After 6 and 12-weeks of exercise training, there were no significant changes in body 
mass, BMI or waist-to-hip ratio. However, both systolic and diastolic blood pressure was 
significantly reduced after 12-weeks of exercise training (p > 0.05). Plasma ADMA 
concentration was found to be significantly lower after 12-weeks exercise training from 
baseline measurements (wk 0) (p < 0.05; Table 1; Figure 1). No significant changes 
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were found in other blood or lipid profile measurements after 12-weeks of exercise 
training (p > 0.05) (Table 1). 
 
Twelve weeks of exercise training at an intensity equivalent to Tge (72-74 % VO2peak) 
resulted in significant increases in time to exhaustion, absolute and relative VO2peak, and 
VO2 at Tge (p < 0.05) (Table 1). 
 
4.4 Discussion and Conclusions 
 
Our study found that 12-weeks of moderate-intensity exercise training (120 minutes per 
week at an intensity equivalent to individual Tge) significantly lowered plasma 
concentration of circulating ADMA in women aged 65-74 years with type 2 diabetes. To 
our knowledge, this is the first study showing clinical evidence for exercise as a 
therapeutic intervention to lower ADMA concentration in older women with type 2 
diabetes.    
 
Participants in the present study had plasma ADMA levels consistent with those found in 
other studies of post-menopausal women (Sydow et al. 2010). In agreement with the 
present study, exercise-induced decreases in systemic ADMA concentration have been 
previously reported in different populations (Hanssen et al. 2011; Mittermayer et al. 
2005; Richter et al. 2005; Schlager et al. 2011; Sydow et al. 2010; Tsarouhas et al. 2011). 
Moderate-intensity, supervised exercise has shown to decrease plasma ADMA in 
participants with peripheral arterial disease (Schlager et al. 2011), chronic heart failure 
(Tsarouhas et al. 2011), obesity (Hanssen et al. 2011), elevated cardiovascular risk 
(Richter et al. 2005), and type 1 diabetes (Mittermayer et al. 2005). Exercise training has 
also been shown to be ineffective in decreasing plasma ADMA (Niebauer et al. 2005). 
Plasma ADMA concentration was unaffected by 2 months of unsupervised, home-based 
exercise training in heart failure patients (Niebauer et al. 2005). ADMA concentration 
was similar between patients and control participants, and normal ADMA concentrations 
might not have been further lowered by exercise. Plasma ADMA concentration was also 
found to be unaffected by 16 weeks of supervised exercise training in another cohort of 
heart failure patients (Seljeflot et al. 2011). However, the exercise dose may have been 
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insufficient to elicit a decrease in ADMA concentration as the exercise mode (dancing) 
was performed in a group environment and music speed was used to moderate intensity 
according self-reported rating of perceived exertion (Seljeflot et al. 2011). Unlike the 
present study, exercise stimulus was not individualized nor linked to a physiological 
marker such as Tge. 
 
In the present study, twelve weeks of moderate-intensity exercise training resulted in 
significant improvements in multiple measures of physiological functional capacity, 
including TE, VO2peak, and VO2 at Tge. These improvements were accompanied by 
significant decreases in both systolic and diastolic blood pressure following twelve weeks 
of exercise. The exercise-induced reductions in ADMA plasma concentration has been 
reported elsewhere (Hanssen et al. 2011; Mittermayer et al. 2005; Richter et al. 2005; 
Schlager et al. 2011; Sydow et al. 2010; Tsarouhas et al. 2011), the mechanisms behind 
this process are not clear. ADMA’s cardiovascular effects include vasoconstriction and 
increased blood pressure (Achan et al. 2003; Kielstein et al. 2004) and may explain, in 
part, the significant reduction in BP seen in the present study after 12-weeks of exercise 
training. This argument may be strengthened by research suggesting that exercise-
induced increases in NO bioavailability may be due, at least in part, to decreases in 
ADMA concentration (Gomes et al. 2008).  
 
It has been hypothesized that regular exercise decreases ADMA concentration by 
upregulating dimethylarginine dimethylaminohydrolase 1 (DDAH-1), an enzyme 
involved in ADMA decomposition (Mittermayer et al. 2005). Recently, decreased 
ADMA concentration following exercise training has been shown to be accompanied by 
enhanced DDAH-1 mRNA gene-expression (Hanssen et al. 2011). Upregulation of 
DDAH-1 and subsequent decreased ADMA concentration through regular exercise may 
be influenced by antioxidant status. Recent work has suggested that aging-associated 
oxidant/antioxidant imbalance promotes the formation cardiovascular risk factors, 
including ADMA, via increases in systemic oxidative stress in elderly individuals (Fabian 
et al. 2011). Unfortunately, no measure of oxidative stress was measured in the present 
study and these findings cannot be confirmed. 
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The significant decrease in circulating plasma ADMA concentration in the present study 
was not accompanied by significant improvements in conventional markers of CVD risk 
factors, including homocysteine concentration. The reduction in plasma ADMA 
concentration may be independent of homocysteine and may act as a sensitive marker of 
CVD risk in medically well-managed patients who may not show more conventional 
signs of CVD risk.  
 
Our study’s limitations include: extrapolation of the results beyond the cohort of 
participants in the present study. While subject recruitment proved to be very difficult 
due to the significant time requirements of the exercise training program and the use of a 
repeated measure design, the modest sample size used in our study needs to be 
acknowledged as a potential limitation, but mitigated by the present experimental design.  
 
In conclusion, 12-weeks moderate-intensity exercise training (walking) can significantly 
reduce circulating plasma ADMA concentration and systolic and diastolic blood pressure 
in women aged 65-74 years with type 2 diabetes. Our study suggests that the decreased 
incidence of vascular disease associated with regular exercise in type 2 diabetes may be, 
in part, explained by decreased circulating plasma ADMA concentration. 
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Table 1.  Clinical characteristics of participating subjects before (wk -6) and after (wk 0) 6-week  
intervention-free control period and after 6 and 12-weeks of exercise training. Mean ± 
SEM. 
 
Week -6 
(n=14) 
Week 0 
(n=14) 
Week 6 
(n=14) 
Week 12 
(n=14) 
Age (yr) 68.9±0.7 68.9±0.7 68.9±0.7 68.9±0.7 
Body Mass (kg) 76.5±3.7 75.9±3.8 76.2±3.9 76.4±3.8 
BMI (kg·m-2) 30.2±1.4 30.0±1.4 30.1±1.4 30.1±1.4 
Waist/Hip Ratio  0.86±0.02 0.85±0.02 0.86±0.02 0.86±0.02 
Blood Pressure (mmHg)     
SBPrest  134±3 133±2 130±3 122±3* 
DBPrest 76±2 75±2 70±2 69±2* 
Blood Profile     
ADMA (µmol·L-1) 0.68±0.04 0.71±0.02 0.69±0.04 0.62±0.03* 
Homocysteine (µmol·L-1) 12.8±1.8 11.6±1.3 11.6±0.9 11.6±0.8 
Glucose (mmol·L-1) 7.4±0.5 7.5±0.5 7.0±0.4 7.2±0.4 
HbA1C (%) 6.6±0.2 6.6±0.2 6.5±0.2 6.7±0.2 
HbA1C (mmol·mol-1) 49±2 49±2 48±2 50±2 
Insulin (mU·L-1) 11.3±2.3 11.0±2.2 12.9±2.6 13.6±3.5 
Exercise Responses     
TE (min) 13.7±0.5 13.9±0.4 15.4±0.4* 16.4±0.4* 
VO2peak (L·min-1) 1.49±0.03 1.45±0.04 1.53±0.05 1.59±0.05* 
VO2peak (mL·kg-1·min-1) 20.0±0.9 19.6±1.1 20.5±0.9 21.4±1.0* 
Peak HR (b·min-1) 143±3 141±5 144±4 145±3 
VE peak (L·min-1) 51.7±1.8 50.8±2.4 55.2±2.4* 54.2±2.5 
VO2Tge (L·min-1) 1.04±0.03 1.01±0.04 1.04±0.04 1.12±0.05* 
Peak RER 1.10±0.02 1.11±0.03 1.13±0.03 1.07±0.02 
 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated 
haemoglobin; TE, time to exhaustion; VO2peak, peak oxygen uptake; HR, heart rate; VE, ventilation; VO2 
Tge, oxygen uptake at gas-exchange threshold; RER, respiratory exchange ratio. 
*, p < 0.05, significantly different to pre-training (wk 0). 
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Figure 1.  Changes in plasma ADMA concentration
 
() during 6-week control period (wk -6 to 
wk 0), and after 6 and 12-weeks of exercise training (wk 0 to wk 6 to wk 12). Mean ± 
SEM.  *, p < 0.05, significantly different to pre-training (wk 0). 
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Although the risk of disease and disability clearly increases with 
advancing age, poor health is not an inevitable consequence of 
aging.......Proven, effective strategies to prevent chronic disease, 
disability, and death exist, but they have not been widely used. 
Physical activity is the key to healthy aging. Nowhere is the gap 
wider between what we know and what we do than in the area of 
physical activity. Nowhere is the potential payoff greater. 
              -  (Koplan 2000)  
 
CVD is a major cause of morbidity and mortality in older individuals with type 2 diabetes 
(Astrup 2011). While the benefits of regular exercise on vascular function in individuals 
with type 2 diabetes are well established (Maiorana et al. 2001; Okada et al. 2010), the 
mechanisms behind these benefits are unclear. Thus, the primary aim of this thesis was to 
understand select responses in vascular structure (RVC and Df) and ADMA concentration 
to moderate-intensity exercise (walking) in women aged 65-74 yr with type 2 diabetes.  
Data from this study may help in establishing measurements of retinal microvascular 
structure (RVC and Df) and AMDA concentration as novel therapeutic targets for the 
prevention of CVD in older patients with type 2 diabetes.   
 
5.1 Review of Findings 
 
In Chapter Two (Study One), we report the relationship between measures of 
physiological functional capacity and retinal microvascular structure in older women with 
and without type 2 diabetes. Until the present study, the relationship between VO2peak 
and TE, direct measures of PFC and retinal microvascular structure had not been 
examined. Thus, it is unknown whether moderate-intensity exercise has long-term 
beneficial effects on the retinal vasculature. In the present study no significant 
relationship was found between any measures of PFC and retinal vessel calibre. 
However, a significantly higher Df was found to be positively correlated with time to 
exhaustion in subjects with type 2 diabetes. These results are not surprising given that 
quantifying retinal vascular complexity using Df has been suggested to provide a more 
accurate and sensitive overall estimate of retinal microvascular structure than vessel 
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calibre alone (Liew et al. 2008b). The results of our study suggest that retinal vascular 
branching pattern is more complex in those individuals who had a longer time to 
exhaustion during graded exercise testing. Further investigations involving a larger, more 
diverse population with regards to PFC are required to determine if any other 
relationships between retinal microvascular structure and measures of PFC exist. 
 
Chapter Three (Study Two) expands on the results of Chapter Two (Study One) by 
investigating the effects of a 12-week exercise intervention (walking) on RVC and Df in 
women aged 65-74 years with type 2 diabetes. While a few studies have examined the 
relationship between physical activity and retinal microvascular structure (Anuradha et 
al. 2011a; Anuradha et al. 2011b; Anuradha et al. 2011c; Tikellis et al. 2010), it was 
previously unknown whether supervised, moderate-intensity exercise would have long-
term beneficial effects on the retinal vasculature. In our study, 12-weeks of supervised, 
moderate-intensity walking at an intensity equivalent to Tge did not result in significant 
changes in mean RVC or Df, despite significant increases in VO2peak, TE, VO2 at Tge, as 
well as significant reductions in systolic and diastolic blood pressure. These results 
suggest that retinal microvascular structure may not be a useful clinical marker to 
measure the effectiveness of exercise as a therapeutic intervention for the prevention of 
CVD in older women with type 2 diabetes, or that the duration of the exercise training 
program needs to be expanded. Further investigation with a longer duration of exercise 
and a range of exercise intensities may help to clarify the relationships between retinal 
microvascular structure and physical activity.  
 
In Chapter Four (Study Three), the effects of moderate-intensity exercise on another 
potential clinical marker of CVD risk, ADMA, was examined in the same cohort as the 
previous two studies. ADMA is elevated in patients with type 2 diabetes and thought to 
play a role in the endothelial dysfunction and increased CVD risk associated with type 2 
diabetes (de Jager et al. 2006; Malecki et al. 2007; Yamagishi et al. 2008). While exercise 
has been shown to reduce ADMA concentration in certain populations (Gomes et al. 
2008; Mittermayer et al. 2005; Richter et al. 2005), no studies to date have examined the 
effects of exercise on ADMA concentration in individuals with type 2 diabetes. In our 
study, plasma ADMA concentration was found to be significantly lower after 12-weeks 
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of moderate exercise training, suggesting that ADMA may play a role in the training-
induced reduction in cardiovascular disease risk seen with exercise training in individuals 
with type 2 diabetes. Importantly, these reductions in ADMA were not accompanied by 
significant improvements in homocysteine concentration and may therefore act as a more 
sensitive marker of CVD risk in medically well-managed patients who may not show 
more conventional signs of CVD risk. 
 
5.2 Discussion 
 
Currently, the American Diabetes Association suggests that individuals with type 2 
diabetes should follow physical activity guidelines outlined for the general population 
(American Diabetes Association 2012b). The American Diabetes Association 
recommends that individuals with diabetes, regardless of age, should “perform at least 
150 min/week of moderate intensity aerobic physical activity (50-70% of maximal heart 
rate)”. The above guidelines are primarily influenced by studies examining the effects of 
exercise on glycaemic control in individuals with type 2 diabetes (Boule et al. 2001; 
Boule et al. 2003). To date, few studies have focused on examining the effectiveness, and 
optimal dosing strategies of exercise on improving markers associated with the 
complications of diabetes. Further studies are required to establish a minimal therapeutic 
dose of exercise for protective cardiovascular responses in older, female individuals with 
type 2 diabetes. Based on our difficulty recruiting subjects to volunteer for this particular 
exercise training study, many older women may not be willing to commit to 150 
min/week of moderate intensity aerobic physical activity. After a significant recruitment 
campaign over a 24-month period starting in 2007, only 20 women meeting inclusion 
criteria volunteered to complete the testing procedures and exercise training program. 
After very little response from newspaper advertisements, radio and television 
announcements, information booths at local shopping centres, and flyers posted at local 
pharmacies, medical centres, diabetes education clinics, pathology laboratories, and 
ophthalmology clinics, a different recruitment strategy was implemented. With the help 
of Diabetes Australia Queensland, 600 recruitment flyers were sent out to individuals 
who lived within a short distance to our testing laboratory and who directly matched our 
inclusion criteria for our study. Despite extensive recruitment efforts, only 55 eligible 
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individuals expressed interest and attended an information session at Bond University. Of 
these individuals, only 20 were willing to participate, with most non-participants citing 
the significant time commitment associated with the study as the reason for not 
participating. The unwillingness of the vast majority of women in this age group to 
commit to an exercise training program consisting of 120 min/week suggests that a more 
convenient and manageable exercise prescription may need to be established for this 
population.  
 
Additional research, with larger subject cohorts, is required to develop a true dose-
response for the beneficial effects of exercise on older women with type 2 diabetes.     
 
Study One and Two are the first studies to examine the effects of increased measures of 
PFC and a 12-week exercise intervention on the microcirculation in individuals with type 
2 diabetes. While 120 min/week of regular exercise at individual Tge did not result in 
significant changes to the retinal microvasculature, measures of vascular complexity (Df) 
were found to be influenced by measures of PFC (TE) in diabetic individuals. Individuals 
who had a longer time to exhaustion during graded exercise testing to volitional fatigue 
had more complex microvascular branching patterns. The mechanisms responsible for the 
relationship between Df and measures of “cardiovascular fitness” are not clear. The 
beneficial vascular adaptations to regular exercise have been shown to be largely 
mediated by changes in vascular structure (Prior et al. 2004), specifically in 
improvements in endothelial function (Vassalle et al. 2003). Therefore, exercise-induced 
changes in endothelial function may contribute to the associations between Df and 
measures of PFC in our study. It has been suggested that regular exercise training may 
improve endothelial function by enhancing NO bioavailability (Goto et al. 2003; Green et 
al. 2004; Maeda et al. 2001). Retinal microvascular tone is mainly regulated by NO and it 
has been suggested that NO bioavailability may influence retinal arterial vessel structure 
(Hanssen et al. 2011). While the underlying mechanisms behind the relationship between 
retinal microvascular structure and NO are likely complex, results from Study Three 
suggest that systemic ADMA concentrations may play a role in the association between 
retinal microvascular structure and NO. 
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Study Three found that in older women with type 2 diabetes, regular, moderate-intensity 
exercise decreases circulating plasma ADMA concentration.  The decrease in systemic 
ADMA concentration with exercise may have influenced retinal angiogenesis and 
contributed to the association between Df and TE observed in Study One. Previous 
studies have linked retinal fractal dimension to retinal angiogenesis (Masters 2004; 
Misson et al. 1992). One possible mechanism for the relationship between retinal Df and 
angiogenesis is the dysregulation of the ADMA/DDAH pathway, which has been found 
to be associated with impaired angiogenesis (Fiedler et al. 2009). Further studies are 
warranted to develop our understanding of the relationship between retinal microvascular 
complexity and ADMA. 
 
5.3 Conclusions 
 
The findings presented in this thesis support the use of regular, moderate-intensity 
exercise as an effective intervention for the management of type 2 diabetes in older 
women. Moreover, the data suggest that: 
 
1 In older women with type 2 diabetes, retinal vascular branching pattern is more 
complex in individuals with higher “cardiovascular fitness”, as measured by time 
to exhaustion during incremental exercise testing.  
2 In older women with type 2 diabetes, twelve weeks of supervised exercise 
training did not improve retinal microvascular calibre or fractal dimension. These 
results suggest that changes in retinal microvascular structure may not be a useful 
clinical tool for measuring the effectiveness of regular exercise as a therapeutic 
intervention for the prevention of cardiovascular disease.  
3 In older women with type 2 diabetes, twelve weeks of supervised exercise 
training at Tge resulted in significant increases in TE, VO2peak, VO2peak relative 
to body mass, RER, VO2 at Tge, heart rate at Tge and significant decreases in 
systolic and diastolic blood pressure. 
4 Regular exercise has the potential to decrease systemic ADMA concentrations in 
older women, which may be a potential mechanism underlying the relationship 
found between retinal vascular complexity and measures of physiological 
functional capacity. 
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Physical Activity Readiness Questionnaire 
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Type 2 Diabetes Exercise Research Program 
 
Date 
Dear Subject Name, 
Thank you for your continued interest and enthusiasm in our Type 2 diabetes exercise research program. 
We would now like to invite you to commence the first Pre-training Testing Session. However, before 
commencing your participation in our project, we ask that you obtain medical clearance from your own 
doctor (i.e., your GP) to participate in the program. 
 
We have included with this letter: i. a copy of your blood results, ii. a copy of all your pre-exercise 
screening information, iii. a letter for your GP to sign indicating his/her recommendation about your 
participation in the exercise program, and iv. a reply postage-paid envelope for your GP to return their 
recommendation to us.  
 
Please visit your GP within the next 5-7 days with all pre-exercise screening information in the envelope 
for his/her inspection. Your GP then will be able to make the recommendation about your participation in 
our research program.  
 
We appreciate your continued interest for our project. If you have any questions regarding this letter, please 
do not hesitate to contact Kevin Serre on 5595 4048. 
 
Yours sincerely, 
 
 
Prof Greg Gass    Dr Clare Minahan 
Chief Investigator   Chief Investigator  
Bond University    Griffith University 
Telephone: (07) 5595 4481  Telephone:  (07) 5552 8531 
Email: ggass@bond.edu.au  Email: c.minahan@griffith.edu.au 
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Date 
 
Re: Subject Name 
«Address» 
«Suburb» «Postcode» 
 
Dear Doctor, 
 
Request for your recommendation regarding the suitability of Subject Name’s participation in our 
research project involving an incremental exercise test to volitional fatigue and a 12-week exercise 
training (walking) program. 
 
Subject Name has volunteered to participate in our research project. Our project is running in parallel to a 
project funded and supported by the Department of Health and Ageing, and will be conducted by Bond 
University and Griffith University. The program is about determining the optimum exercise prescription for 
Type 2 diabetic women aged 65-74 years to improve their health and well-being. 
 
To determine the optimum exercise prescription for health benefits in Type 2 diabetic women aged 65-74 
years, participants will take part in a 12-week walking program. Before, during, and at the end of the 12-
week walking program, we will ask participants to undergo select medical tests, blood tests and exercise 
tests. Our 12-week walking program will involve walking on a treadmill from 1 to 5 days a week. We will 
be asking participants to exercise for a total of 120 minutes every week for 12-weeks at an intensity that is 
equivalent to a brisk walk.  
 
By participating in our research project, Subject Name will be asked to undergo an incremental exercise 
test to volitional fatigue (i.e., Stress Test) under direct medical supervision with immediate access to a fully 
equipped emergency/resuscitation cart. We are aware that exercise stress testing of this nature does carry 
some risk of cardiovascular and/or musculoskeletal misadventure. We are requesting your recommendation 
regarding Subject Name’s suitability to participate in our project. We have included a copy of the pre-
exercise screening information collected from Subject Name to date. 
  
This Pre-exercise screening information includes:  
• A medical history questionnaire,  
• Selected blood analyses,  
• Resting 12-lead ECG data, and  
• Resting spirometry results. 
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In making your recommendation, the research team asks that you carefully consider Subject Name’s 
medical history, and in particular: 
 
a. «Problem_1» 
b. «Problem_2» 
c. «Problem_3» 
d. «Problem_4» 
 
We have also included the exercise program’s information sheet that details the walking program, 
scheduled tests, and participant responsibilities. If you have any further questions you would like answered, 
please contact Kevin Serre on 5595 4048.  
 
We would appreciate it if you could complete the attached GP recommendation form and return it in the 
reply-paid envelope provided, at your earliest convenience. 
 
Yours sincerely,  
 
 
 
Prof Greg Gass    Dr Clare Minahan 
Chief Investigator   Chief Investigator  
Bond University    Griffith University 
Telephone: (07) 5595 4481  Telephone:  (07) 5552 8531 
Email: ggass@bond.edu.au  Email: c.minahan@griffith.edu.au 
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Type 2 Diabetes Exercise Research Program - GP RECOMMENDATION 
The NH&MRC project exclusion criteria is provided below. 
 
 
Cardiac 
• A recent significant change in resting ECG suggesting ischemia or recent myocardial infarction. 
• Unstable angina 
• Uncontrolled cardiac dysrhythmias 
• Uncontrolled heart failure 
• Severe aortic stenosis 
• Pulmonary embolus or pulmonary infarction 
• Heart murmur 
• Suspected or known dissecting aneurysm 
Metabolic 
• Type I Diabetes 
Other 
• Mental or physical impairment leading to inability to exercise adequately 
• Cigarette smokers 
 
If you believe your patient is suitable for this research project we would be pleased for you to recommend 
their participation. 
 
I, _________________________________, a Medical Practitioner registered in the State of Queensland, 
have reviewed Subject Name’s screening information provided by the research team.  In conjunction with 
my own records and the NH&MRC Project Exclusion Criteria provided in the box above 
 
I do recommend / I do not recommend (please circle one) Subject Name participate in the exercise 
program as outlined in the Information Sheet. 
 
In giving my recommendation that Subject Name participate in this research project, I acknowledge that I 
am not liable in anyway for any adverse event or injury that may be sustained during or resulting from the 
project. I am providing my medical opinion of her suitability to participate in this research as outlined in 
the Information Sheet. 
 
 
Doctor’s full name (printed):  
Provider Number:  
Doctor’s signature:  Date:  
 
Surgery/Practice Contact details: 
Phone:  Fax:  
Address:  
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All blood samples were collected by an accredited phlebotomist. Subjects were asked to 
refrain from moderate-to-vigorous physical activity and the consumption of alcohol of 
caffeine for at least 24 h prior to blood collection. All samples were collected following 
an overnight (~12 h) fast to ensure food and fluid intake was standardised. All blood 
samples were collected within 90 s of tourniquet application using a 21 gauge needle. 
EDTA was used as an anticoagulant and all analyses were completed within 3 h of blood 
collection. Methodology and instrumentation used for each dependent variable is listed 
below.  
 
Measure Instrument Methodology 
Insulin Abbott Architect® Chemiluminescent microparticle immunoassay 
Homocysteine Abbott Architect® Chemiluminescent microparticle immunoassay 
Glucose Roche Cobas® Modular Enzymatic (hexokinase) 
HbA1c Bio-rad Variant™ II High-performance liquid chromatography 
Cholesterol Roche Cobas® Modular Enzymatic (esterase and cholesterol oxidase) 
Triglycerides Roche Cobas® Modular Enzymatic (hexokinase) 
High-density 
Lipoprotein Roche Cobas
®
 Modular Homogeneous PEG-treated enzymatic 
Low-density 
Lipoprotein Roche Cobas
®
 Modular Calculated or Enzymatic (if Trig>4.5 mmol/L) 
Red Blood Cell Sysmex® XT-2000i Hydro Dynamic Focusing 
White Blood Cell Sysmex® XT-2000i Flow Cytometry 
Haemoglobin Sysmex® XT-2000i Sodium Lauryl Sulphate haemoglobin detection 
 
